The combined discipline of psychology and economics that investigates what happens in markets in which some of the agents display human limitations and complications.
The science of utilization, distribution, and consumption of services and materials.
Economic aspects of the field of medicine, the medical profession, and health care. It includes the economic and financial impact of disease in general on the patient, the physician, society, or government.
The economic aspects of health care, its planning, and delivery. It includes government agencies and organizations in the private sector.
Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.
Economic aspects related to the management and operation of a hospital.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))
Economic aspects of the nursing profession.
Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.
A theoretical technique utilizing a group of related constructs to describe or prescribe how individuals or groups of people choose a course of action when faced with several alternatives and a variable amount of knowledge about the determinants of the outcomes of those alternatives.
The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.
Economic aspects of the dental profession and dental care.
The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)
The intrinsic moral worth ascribed to a living being. (Bioethics Thesaurus)
The moral and ethical obligations or responsibilities of institutions.
The branch of psychology concerned with the effects of group membership upon the behavior, attitudes, and beliefs of an individual.
Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer.
The process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea.
Higher plants that live primarily in terrestrial habitats, although some are secondarily aquatic. Most obtain their energy from PHOTOSYNTHESIS. They comprise the vascular and non-vascular plants.
The obtaining and management of funds for institutional needs and responsibility for fiscal affairs.
Theoretical construct used in applied mathematics to analyze certain situations in which there is an interplay between parties that may have similar, opposed, or mixed interests. In a typical game, decision-making "players," who each have their own goals, try to gain advantage over the other parties by anticipating each other's decisions; the game is finally resolved as a consequence of the players' decisions.
Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system.
Games designed to provide information on hypotheses, policies, procedures, or strategies.
The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).
Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. (From Facts on File Dictionary of Health Care Management, 1988)
The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
Economic sector concerned with the provision, distribution, and consumption of health care services and related products.
Those funds disbursed for facilities and equipment, particularly those related to the delivery of health care.
The expenses incurred by a hospital in providing care. The hospital costs attributed to a particular patient care episode include the direct costs plus an appropriate proportion of the overhead for administration, personnel, building maintenance, equipment, etc. Hospital costs are one of the factors which determine HOSPITAL CHARGES (the price the hospital sets for its services).
Private, not-for-profit hospitals that are autonomous, self-established, and self-supported.
The act of making a selection among two or more alternatives, usually after a period of deliberation.
The decision process by which individuals, groups or institutions establish policies pertaining to plans, programs or procedures.
Use for articles on the investing of funds for income or profit.
The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or personal loss to self, family, or immediate community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, or QUALITY OF LIFE. It differs from HEALTH CARE COSTS, meaning the societal cost of providing services related to the delivery of health care, rather than personal impact on individuals.
The concept concerned with all aspects of providing and distributing health services to a patient population.
An act which constitutes the termination of a given instinctive behavior pattern or sequence.
Planning for the equitable allocation, apportionment, or distribution of available health resources.
Societal or individual decisions about the equitable distribution of available resources.
Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994)
Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION.
Auditory and visual instructional materials.
Amounts charged to the patient as payer for health care services.
Abstract standards or empirical variables in social life which are believed to be important and/or desirable.
The scientific disciplines concerned with the embryology, anatomy, physiology, biochemistry, pharmacology, etc., of the nervous system.
The assignment, to each of several particular cost-centers, of an equitable proportion of the costs of activities that serve all of them. Cost-center usually refers to institutional departments or services.
Activities concerned with governmental policies, functions, etc.
An interactive process whereby members of a community are concerned for the equality and rights of all.
A course or method of action selected, usually by a government, from among alternatives to guide and determine present and future decisions.
Governmental levies on property, inheritance, gifts, etc.
The application of scientific knowledge to practical purposes in any field. It includes methods, techniques, and instrumentation.
Disciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology.
Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level.
Costs which are directly identifiable with a particular service.
Consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence.
The concept pertaining to the health status of inhabitants of the world.
The science of breeding, feeding and care of domestic animals; includes housing and nutrition.
Great Britain is not a medical term, but a geographical name for the largest island in the British Isles, which comprises England, Scotland, and Wales, forming the major part of the United Kingdom.
Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.
The condition in which reasonable knowledge regarding risks, benefits, or the future is not available.
Instructional materials used in teaching.
Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)
Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services.
The non-susceptibility to infection of a large group of individuals in a population. A variety of factors can be responsible for herd immunity and this gives rise to the different definitions used in the literature. Most commonly, herd immunity refers to the case when, if most of the population is immune, infection of a single individual will not cause an epidemic. Also, in such immunized populations, susceptible individuals are not likely to become infected. Herd immunity can also refer to the case when unprotected individuals fail to contract a disease because the infecting organism has been banished from the population.
The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed)
The study of NUTRITION PROCESSES as well as the components of food, their actions, interaction, and balance in relation to health and disease.
Any behavior caused by or affecting another individual, usually of the same species.
Encouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care.
The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs (HEALTH CARE COSTS) and may or may not be shared among the patient, insurers, and/or employers.
The observable response of a man or animal to a situation.
Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.
Communication, in the sense of cross-fertilization of ideas, involving two or more academic disciplines (such as the disciplines that comprise the cross-disciplinary field of bioethics, including the health and biological sciences, the humanities, and the social sciences and law). Also includes problems in communication stemming from differences in patterns of language usage in different academic or medical disciplines.
Any substances taken in by the body that provide nourishment.
Extensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them.
A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent.
Preferentially rated health-related activities or functions to be used in establishing health planning goals. This may refer specifically to PL93-641.
Published materials which provide an examination of recent or current literature. Review articles can cover a wide range of subject matter at various levels of completeness and comprehensiveness based on analyses of literature that may include research findings. The review may reflect the state of the art. It also includes reviews as a literary form.
The reciprocal interaction of two or more persons.
Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli.
Theoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment.
An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)
The process by which decisions are made in an institution or other organization.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
I'm sorry for any confusion, but the term "Maryland" is not a recognized medical term with a specific definition in the medical field. It refers to a state in the United States. If you have any questions about a medical condition or treatment, I would be happy to try and help answer those!
The protection, preservation, restoration, and rational use of all resources in the total environment.
Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).
Disorders caused by nutritional imbalance, either overnutrition or undernutrition.
The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest.
The interaction of two or more persons or organizations directed toward a common goal which is mutually beneficial. An act or instance of working or acting together for a common purpose or benefit, i.e., joint action. (From Random House Dictionary Unabridged, 2d ed)
An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.
The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283)
Health insurance plans intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as HEALTH MAINTENANCE ORGANIZATIONS and PREFERRED PROVIDER ORGANIZATIONS.
I'm sorry for any confusion, but 'Europe' is a geographical continent and not a medical term; therefore, it doesn't have a medical definition.
The strengthening of a conditioned response.
An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure.
The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.
Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.
The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.
A course of study offered by an educational institution.
Insurance providing coverage of medical, surgical, or hospital care in general or for which there is no specific heading.
Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data.
Health services required by a population or community as well as the health services that the population or community is able and willing to pay for.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
A situation in which the level of living of an individual, family, or group is below the standard of the community. It is often related to a specific income level.
Social and economic factors that characterize the individual or group within the social structure.
Regular course of eating and drinking adopted by a person or animal.
Revenues or receipts accruing from business enterprise, labor, or invested capital.
The pattern of any process, or the interrelationship of phenomena, which affects growth or change within a population.
Federal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance (MEDICARE PART A) and supplementary medical insurance (MEDICARE PART B). (Hospital Administration Terminology, AHA, 2d ed and A Discursive Dictionary of Health Care, US House of Representatives, 1976)
Elements of limited time intervals, contributing to particular results or situations.
A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
The period of medical education in a medical school. In the United States it follows the baccalaureate degree and precedes the granting of the M.D.
Research that involves the application of the natural sciences, especially biology and physiology, to medicine.
Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.
Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. (American Heritage Dictionary, 2d ed)
The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics.
Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.
Computer-based representation of physical systems and phenomena such as chemical processes.
Disorders related to substance abuse.
The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
The levels of excellence which characterize the health service or health care provided based on accepted standards of quality.
Intellectual or mental process whereby an organism obtains knowledge.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
A functional system which includes the organisms of a natural community together with their environment. (McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed)
A country spanning from central Asia to the Pacific Ocean.
Application of statistical procedures to analyze specific observed or assumed facts from a particular study.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
The period of confinement of a patient to a hospital or other health facility.
A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.
The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Statistical formulations or analyses which, when applied to data and found to fit the data, are then used to verify the assumptions and parameters used in the analysis. Examples of statistical models are the linear model, binomial model, polynomial model, two-parameter model, etc.
The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others.
Inhaling and exhaling the smoke of burning TOBACCO.
Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192)
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.

The three dimensions of managed care pharmacy practice. (1/161)

Our goal is to provide a framework for pharmacy in an evolving healthcare marketplace by identifying and discussing the three dimensions of pharmacy practice: (1) pharmacy practice across the continuum of care; (2) the major elements of pharmacy practice; and (3) the evolution of pharmacy during the five stages of the development of managed care. The framework was devised under the proposition that there is a substantial consistency in what patients need or should expect from pharmacists. As integrated health systems develop, pharmacists must apply their skills and knowledge across the continuum of care to ensure that they play an integral part in the systems. In a managed care environment characterized by change and the development of integrated health systems, pharmacists have opportunities to become involved directly in patient care in such areas as disease prevention, home healthcare, primary care, and subacute care. Information systems, hospital drug distribution, clinical pharmacy, and the fiscal environment comprise the major elements of pharmacy practice within an integrated health system, and the way in which each of these elements evolves as the healthcare market adapts to managed care is critical to pharmacy practice. If the pharmacy profession can demonstrate its ability to manage disease and health, improve outcomes, and reduce costs within the evolving healthcare system, pharmacists will play a vital role in the managed healthcare market in the approaching new millennium.  (+info)

Effectiveness and economic impact of antidepressant medications: a review. (2/161)

This article reviews the existing literature on the pharmacoeconomics and effectiveness of antidepressant medications. Although selective serotonin reuptake inhibitors (SSRIs) have not proved to be more efficacious than the older tricyclics, and their prescription costs are significantly higher, they provide superior effectiveness; ie, patients are less likely to discontinue taking them or switch antidepressants. Pharmacoeconomic studies consistently demonstrate a relationship between this superior effectiveness and reductions in overall treatment costs, often through decreased utilization of medical and hospital services. The most conservative study found a cost offset that more than negated the extra cost of drugs, although the cost savings were not statistically significant. Other studies found statistically significant lowering of utilization costs by using SSRIs rather than tricyclics. Studies comparing SSRIs with each other present conflicting findings, although fluoxetine appears to have an edge over sertraline and paroxetine with regards to effectiveness and pharmacoeconomics. More studies employing a prospective outcome design and naturalistic study setting need to be conducted with SSRIs and other new antidepressants.  (+info)

The challenge of integrating monoclonal antibodies into the current healthcare system. (3/161)

Although there are few monoclonal antibody (MoAb) products on the market, the biotechnology industry has made considerable progress over the last decade. The industry has developed new technology to address the primary hurdles facing the development of MoAbs--including the immune response to murine-derived antibodies as well as lack of tumor specificity. As the techniques for development become more refined, more products will be approved by the Food and Drug Administration. Integrating these products into the existing healthcare system will be a challenge, given their high acquisition costs. Recent pharmacoeconomic examples outlined in this paper confirm that MoAb products will need to be supported with proven clinical and economic profiles. As long as a global clinical and economic perspective is taken and patient care benefits can be demonstrated, the place of MoAbs in the future of healthcare will be assured.  (+info)

Managed care guidelines for the economic evaluation of pharmaceuticals. (4/161)

Foundation Health Corporation, through its National Pharmacy and Therapeutics Committee, requires all pharmaceutical manufacturers and others who wish products to be considered for formulary listing to meet evidentiary and analytical standards in their submission documentation. This article details the evidentiary and analytical standards required from those making submissions and describes the methodological basis of the guidelines. This is the first time, as far as the authors are aware, that a managed care health system in the United States has required formulary submissions not only to meet clinical and economic evaluation standards, but also to take explicit account of the perspective of the managed care group in applying these techniques. Submissions are required to take what is described as a systems impact perspective. This approach is quite different, in both evidentiary and analytical terms, from standards required by health systems in other countries and standards for the economic evaluation of pharmaceuticals proposed by expert groups in the United States.  (+info)

Financing pharmaceuticals in transition economies. (5/161)

This paper (a) provides a methodological taxonomy of pricing, financing, reimbursement, and cost containment methodologies for pharmaceuticals; (b) analyzes complex agency relationships and the health versus industrial policy tradeoff; (c) pinpoints financing measures to balance safety and effectiveness of medicines and their affordability by publicly funded systems in transition; and (d) highlights viable options for policy-makers for the financing of pharmaceuticals in transition. Three categories of measures and their implications for pharmaceutical policy cost containing are analyzed: supply-side measures, targeting manufacturers, proxy demand-side measures, targeting physicians and pharmacists, and demand-side measures, targeting patients. In pursuing supply side measures, we explore free pricing for pharmaceuticals, direct price controls, cost-plus and cost pricing, average pricing and international price comparisons, profit control, reference pricing, the introduction of a fourth hurdle, positive and negative lists, and other price control measures. The analysis of proxy-demand measures includes budgets for physicians, generic policies, practice guidelines, monitoring the authorizing behavior of physicians, and disease management schemes. Demand-side measures explore the effectiveness of patient co-payments, the impact of allowing products over-the-counter and health promotion programs. Global policies should operate simultaneously on the supply, the proxy demand, and the demand-side. Policy-making needs to have a continuous long-term planning. The importation of policies into transition economy may require extensive and expensive adaptation, and/or lead to sub-optimal policy outcomes.  (+info)

How should managed care treat onychomycosis? (6/161)

This activity is designed for leaders and managers of managed care organizations and for primary care physicians and specialists involved in evaluating, treating, and caring for patients with onychomycosis. GOAL: To help health professionals care for patients with onychomycosis through a discussion of new treatment choices that exist due to recently approved oral antifungal agents for this chronic medical condition. OBJECTIVES: 1. Review the anatomy of the nail unit in relation to the pathogenesis, epidemiology, and clinical features of onychomycosis. 2. Stress the importance of confirming the diagnosis of onychomycosis using relatively simple and cost-effective laboratory procedures, since there are many other nonfungal conditions that can pathologically involve the nail unit. 3. Detail the ways in which onychomycosis can adversely affect a patient's quality of life. 4. Analyze the change in treatment patterns brought about by newer potentially curative oral antifungal therapy. 5. Identify potential problems with onychomycosis oral antifungal therapy, including dosing issues, possible adverse events, and drug-drug interactions.  (+info)

Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors. (7/161)

BACKGROUND: Reference-based pricing is a cost-containment policy applied to prescription drugs that are in the same class and deemed to be therapeutically equivalent. Recent reference-based pricing measures have targeted several drug classes, including angiotensin-converting-enzyme (ACE) inhibitors. The objective of this study was to assess whether patients treated for hypertension with various ACE inhibitors differed in their utilization of health care services and hence, whether the various ACE inhibitors should be considered therapeutically equivalent. METHODS: A retrospective cohort was formed from 4709 Saskatchewan residents aged 40-79 years who initiated treatment for hypertension with 1 of the 3 most frequently prescribed ACE inhibitors (captopril, enalapril or lisinopril) between Jan. 1, 1991, and Dec. 31, 1993. Information obtained from universal insurance databases included prescription drug use, the number of visits to a general practitioner (GP) or specialist and the number of hospital admissions during the year before treatment was initiated and during a follow-up period of up to 4 years. Rates were statistically adjusted for potential confounding variables and compared across treatment groups. RESULTS: Of the 4709 patients, 529 were prescribed captopril initially, 2939 enalapril and 1241 lisinopril. After treatment was initiated patients prescribed captopril were dispensed more medications on average, with an overall rate of 18.6 prescriptions per patient per year (v. 16.4 and 14.7 for enalapril and lisinopril users respectively); they were admitted to hospital more often, and they made more visits to GPs and specialists. The adjusted rate ratio of the number of visits to a GP for patients receiving enalapril, relative to captopril, was 0.84 (95% confidence interval [CI] 0.80-0.88), and for those receiving lisinopril it was 0.79 (95% CI 0.74-0.83). The adjusted rate ratios for the number of visits to a specialist were similar but lower, and for the number of hospital admissions they were 0.82 for patients prescribed enalapril initially (95% CI 0.73-0.93) and 0.65 (95% CI 0.56-0.75) for those prescribed lisinopril. INTERPRETATION: Patients with hypertension who are initially prescribed captopril used health care services more than those initially prescribed enalapril or lisinopril. This suggests that ACE inhibitors may not be therapeutically equivalent.  (+info)

Evaluating reference-based pricing: initial findings and prospects. (8/161)

Reference-based pricing is a controversial policy mechanism used to control pharmaceutical expenditures. After its implementation in some European countries, the British Columbia government introduced a version of reference-based pricing in October 1995. The authors reviewed previous studies of reference-based pricing in other countries and conducted a preliminary assessment of the impacts of the BC system by analysing secondary utilization and cost data. After the introduction of reference-based pricing in other jurisdictions within the Organisation for Economic Cooperation and Development, there was a temporary reduction in the rate of growth of total pharmaceutical expenditures, followed by a return to previous growth trends in subsequent years. Similarly, initial data from BC showed dramatic declines in annual expenditures for drugs within referenced categories (from $42.0 million the year before reference-based pricing was introduced to $23.7 million the year after). Although early evidence suggests that reference-based pricing in BC is indeed reducing drug expenditures, much more research is needed to make a final determination of its success. A more comprehensive and longitudinal evaluation of reference-based pricing is needed and should take into account a wide range of non-cost impacts, the most important of which are the effects on health outcomes.  (+info)

Behavioral economics in the field of medicine refers to the study of how psychological, social, and emotional factors influence the economic decisions and behaviors of individuals and groups within the healthcare system. This interdisciplinary approach combines insights from psychology, economics, and other social sciences to examine how various factors such as cognitive biases, heuristics, emotions, social norms, and cultural influences affect health-related decision-making by patients, healthcare providers, policymakers, and other stakeholders.

By understanding these behavioral factors, researchers and practitioners can develop more effective interventions, policies, and strategies to improve health outcomes, promote evidence-based practices, reduce healthcare costs, and enhance patient satisfaction and well-being. Examples of applications of behavioral economics in medicine include nudging patients toward healthier choices, reducing overuse and underuse of medical services, promoting shared decision-making between patients and providers, and designing insurance plans and payment systems that incentivize high-value care.

Economics is a social science that studies how individuals, businesses, governments, and societies make choices on allocating resources to satisfy their unlimited wants. It primarily focuses on the production, distribution, and consumption of goods and services.

In healthcare, economics is often referred to as "health economics," which applies economic theory and methods to analyze health care markets, evaluate alternative health policies, and optimize resource allocation in the healthcare sector. Health economists study issues such as the cost-effectiveness of medical treatments, the impact of health insurance on access to care, and the efficiency of different healthcare delivery systems.

Understanding economics is crucial for making informed decisions about healthcare policy, resource allocation, and patient care. By analyzing data and applying economic principles, healthcare professionals can help ensure that resources are used efficiently and effectively to improve health outcomes and reduce costs.

Medical economics is a branch of economics that deals with the application of economic principles and concepts to issues related to health and healthcare. It involves the study of how medical care is produced, distributed, consumed, and financed, as well as the factors that influence these processes. The field encompasses various topics, including the behavior of healthcare providers and consumers, the efficiency and effectiveness of healthcare systems, the impact of health policies on outcomes, and the allocation of resources within the healthcare sector. Medical economists may work in academia, government agencies, healthcare organizations, or consulting firms, contributing to research, policy analysis, and program evaluation.

Health Care Economics refers to the study of how economic principles, theories, and concepts are applied to the production, distribution, and consumption of health care goods and services. It involves analyzing various aspects such as demand and supply of healthcare, pricing of medical services, efficiency and effectiveness of healthcare systems, and the impact of government policies on healthcare markets.

Health Care Organizations, on the other hand, are entities that deliver healthcare services, including hospitals, clinics, group practices, nursing homes, and managed care organizations. These organizations must balance the need to provide high-quality care with the need to operate in a fiscally responsible manner. Health care economics plays a critical role in helping these organizations make informed decisions about resource allocation, pricing strategies, and operational efficiency.

Together, Health Care Economics and Organizations encompass the study of how economic principles are applied to the management and operation of healthcare systems, as well as the impact of these systems on the health and well-being of individuals and populations.

Economic models in the context of healthcare and medicine are theoretical frameworks used to analyze and predict the economic impact and cost-effectiveness of healthcare interventions, treatments, or policies. These models utilize clinical and epidemiological data, as well as information on resource use and costs, to estimate outcomes such as quality-adjusted life years (QALYs) gained, incremental cost-effectiveness ratios (ICERs), and budget impacts. The purpose of economic models is to inform decision-making and allocate resources in an efficient and evidence-based manner. Examples of economic models include decision tree analysis, Markov models, and simulation models.

Hospital economics refers to the study and application of economic principles and concepts in the management and operation of hospitals and healthcare organizations. This field examines issues such as cost containment, resource allocation, financial management, reimbursement systems, and strategic planning. The goal of hospital economics is to improve the efficiency and effectiveness of hospital operations while maintaining high-quality patient care. It involves understanding and analyzing various economic factors that affect hospitals, including government regulations, market forces, technological advancements, and societal values. Hospital economists may work in a variety of settings, including hospitals, consulting firms, academic institutions, and government agencies.

Cost-benefit analysis (CBA) is a systematic process used to compare the costs and benefits of different options to determine which one provides the greatest net benefit. In a medical context, CBA can be used to evaluate the value of medical interventions, treatments, or policies by estimating and monetizing all the relevant costs and benefits associated with each option.

The costs included in a CBA may include direct costs such as the cost of the intervention or treatment itself, as well as indirect costs such as lost productivity or time away from work. Benefits may include improved health outcomes, reduced morbidity or mortality, and increased quality of life.

Once all the relevant costs and benefits have been identified and quantified, they are typically expressed in monetary terms to allow for a direct comparison. The option with the highest net benefit (i.e., the difference between total benefits and total costs) is considered the most cost-effective.

It's important to note that CBA has some limitations and can be subject to various biases and assumptions, so it should be used in conjunction with other evaluation methods to ensure a comprehensive understanding of the value of medical interventions or policies.

Pharmaceutical economics is a branch of economics that focuses on the production and distribution of pharmaceutical products and services. It involves the analysis of various factors that influence the development, pricing, and accessibility of medications, including issues related to healthcare policy, regulation, reimbursement, and market competition.

Pharmaceutical economists study topics such as:

1. The research and development (R&D) process for new drugs, including the costs, risks, and uncertainties associated with bringing a new drug to market.
2. The pricing of pharmaceuticals, taking into account factors such as production costs, R&D expenses, market competition, and the value that medications provide to patients and society.
3. The impact of government regulations and policies on the pharmaceutical industry, including issues related to intellectual property protection, drug safety, and efficacy testing.
4. The role of health insurance and other third-party payers in shaping the demand for and access to pharmaceuticals.
5. The evaluation of pharmaceutical interventions' cost-effectiveness and their impact on healthcare outcomes and patient well-being.
6. The analysis of market structures, competitive dynamics, and strategic decision-making within the pharmaceutical industry.
7. The assessment of globalization, international trade, and cross-border collaboration in the pharmaceutical sector.

Pharmaceutical economics plays a crucial role in informing healthcare policy decisions, improving patient access to essential medications, and promoting sustainable and innovative practices within the pharmaceutical industry.

I'm sorry for any confusion, but "Economics, Nursing" is not a standard medical or nursing term or concept. Economics is the social science that deals with the production, distribution, and consumption of goods and services, while nursing is a field of healthcare concerned with the care of individuals, families, and communities to achieve, maintain, or recover optimal health and quality of life.

If you're looking for information on how economics intersects with nursing or healthcare more broadly, there is a subfield of study known as "health economics" that examines issues related to the financing, delivery, and consumption of healthcare resources. However, I would need more context to provide a more specific definition or explanation.

Costs refer to the total amount of resources, such as money, time, and labor, that are expended in the provision of a medical service or treatment. Costs can be categorized into direct costs, which include expenses directly related to patient care, such as medication, supplies, and personnel; and indirect costs, which include overhead expenses, such as rent, utilities, and administrative salaries.

Cost analysis is the process of estimating and evaluating the total cost of a medical service or treatment. This involves identifying and quantifying all direct and indirect costs associated with the provision of care, and analyzing how these costs may vary based on factors such as patient volume, resource utilization, and reimbursement rates.

Cost analysis is an important tool for healthcare organizations to understand the financial implications of their operations and make informed decisions about resource allocation, pricing strategies, and quality improvement initiatives. It can also help policymakers and payers evaluate the cost-effectiveness of different treatment options and develop evidence-based guidelines for clinical practice.

Decision theory is a branch of mathematical and philosophical study that deals with the principles and methods for making decisions under uncertainty. It provides a framework for analyzing and comparing different decision alternatives based on their potential outcomes, risks, and uncertainties. Decision theory takes into account various factors such as probabilities, utilities, values, and preferences to help individuals or organizations make rational and informed choices.

In medical context, decision theory is often applied to clinical decision-making, where healthcare providers need to evaluate different treatment options for patients based on their individual needs, risks, and benefits. Decision theory can help clinicians to weigh the potential outcomes of different treatments, consider the patient's values and preferences, and make evidence-based decisions that maximize the overall health and well-being of the patient.

Decision theory can also be used in public health policy, healthcare management, and medical research to evaluate the effectiveness and efficiency of different interventions, programs, or policies. By providing a systematic and rigorous approach to decision-making, decision theory can help to improve the quality and transparency of healthcare decisions, reduce uncertainty and bias, and promote better outcomes for patients and populations.

Health care costs refer to the expenses incurred for medical services, treatments, procedures, and products that are used to maintain or restore an individual's health. These costs can be categorized into several types:

1. Direct costs: These include payments made for doctor visits, hospital stays, medications, diagnostic tests, surgeries, and other medical treatments and services. Direct costs can be further divided into two subcategories:
* Out-of-pocket costs: Expenses paid directly by patients, such as co-payments, deductibles, coinsurance, and any uncovered medical services or products.
* Third-party payer costs: Expenses covered by insurance companies, government programs (like Medicare, Medicaid), or other entities that pay for health care services on behalf of patients.
2. Indirect costs: These are the expenses incurred as a result of illness or injury that indirectly impact an individual's ability to work and earn a living. Examples include lost productivity, absenteeism, reduced earning capacity, and disability benefits.
3. Non-medical costs: These are expenses related to caregiving, transportation, home modifications, assistive devices, and other non-medical services required for managing health conditions or disabilities.

Health care costs can vary significantly depending on factors such as the type of medical service, geographic location, insurance coverage, and individual health status. Understanding these costs is essential for patients, healthcare providers, policymakers, and researchers to make informed decisions about treatment options, resource allocation, and health system design.

Dental economics is a branch of economics that focuses on the financial aspects of oral health and dental care. It involves the study of various economic factors that influence the provision, accessibility, affordability, and utilization of dental services. This includes analyzing the costs of dental treatments, pricing strategies, financing options, and insurance policies related to dental care. Additionally, dental economics also examines the impact of government policies, regulations, and market dynamics on dental care delivery and oral health outcomes. The ultimate goal of dental economics is to improve the efficiency, effectiveness, and equity of dental care systems, ultimately leading to better oral health for individuals and populations.

Cost control in a medical context refers to the strategies and practices employed by healthcare organizations to manage and reduce the costs associated with providing patient care while maintaining quality and safety. The goal is to optimize resource allocation, increase efficiency, and contain expenses without compromising the standard of care. This may involve measures such as:

1. Utilization management: Reviewing and monitoring the use of medical services, tests, and treatments to ensure they are necessary, appropriate, and evidence-based.
2. Case management: Coordinating patient care across various healthcare providers and settings to improve outcomes, reduce unnecessary duplication of services, and control costs.
3. Negotiating contracts with suppliers and vendors to secure favorable pricing for medical equipment, supplies, and pharmaceuticals.
4. Implementing evidence-based clinical guidelines and pathways to standardize care processes and reduce unwarranted variations in practice that can drive up costs.
5. Using technology such as electronic health records (EHRs) and telemedicine to streamline operations, improve communication, and reduce errors.
6. Investing in preventive care and wellness programs to keep patients healthy and reduce the need for costly interventions and hospitalizations.
7. Continuously monitoring and analyzing cost data to identify trends, opportunities for improvement, and areas of potential waste or inefficiency.

There is no universally accepted medical definition for "Value of Life" as it is a concept that encompasses both medical, ethical, and philosophical considerations. However, in the context of healthcare, the value of life may refer to the benefits, outcomes, or improvements in quality of life that are gained through medical interventions or treatments. This can include extending lifespan, improving functional ability, relieving symptoms, and enhancing overall well-being.

Ultimately, the value of life is subjective and depends on individual and societal values, beliefs, and preferences. Healthcare providers must consider these factors when making treatment decisions and engaging in end-of-life care discussions with patients and their families. It's important to note that the medical community does not assign a monetary value to human life.

Institutional ethics refers to the ethical principles, guidelines, and practices that are established and implemented within organizations or institutions, particularly those involved in healthcare, research, and other fields where ethical considerations are paramount. Institutional ethics committees (IECs) or institutional review boards (IRBs) are often established to oversee and ensure the ethical conduct of research, clinical trials, and other activities within the institution.

Institutional ethics committees typically consist of a multidisciplinary group of individuals who represent various stakeholders, including healthcare professionals, researchers, community members, and ethicists. The committee's role is to review and approve proposed research studies, ensure that they adhere to ethical guidelines and regulations, protect the rights and welfare of study participants, and monitor ongoing research to identify and address any ethical concerns that may arise during the course of the study.

Institutional ethics also encompasses broader organizational values, policies, and practices that promote ethical behavior and decision-making within the institution. This includes developing and implementing codes of conduct, providing education and training on ethical issues, fostering a culture of transparency and accountability, and promoting open communication and dialogue around ethical concerns.

Overall, institutional ethics plays a critical role in ensuring that organizations and institutions operate in an ethically responsible manner, promote the well-being of their stakeholders, and maintain public trust and confidence.

Social psychology is a branch of psychology that studies how individuals behave, think, and feel in social situations. It examines the ways in which people's thoughts, feelings, and behaviors are influenced by the actual, imagined, or implied presence of others. Social psychologists seek to understand how we make sense of other people and how we understand ourselves in a social context. They study phenomena such as social influence, social perception, attitude change, group behavior, prejudice, aggression, and prosocial behavior.

In summary, social psychology is the scientific study of how people's thoughts, feelings, and behaviors are shaped by their social context and interactions with others.

Cost savings in a medical context generally refers to the reduction in expenses or resources expended in the delivery of healthcare services, treatments, or procedures. This can be achieved through various means such as implementing more efficient processes, utilizing less expensive treatment options when appropriate, preventing complications or readmissions, and negotiating better prices for drugs or supplies.

Cost savings can also result from comparative effectiveness research, which compares the relative benefits and harms of different medical interventions to help doctors and patients make informed decisions about which treatment is most appropriate and cost-effective for a given condition.

Ultimately, cost savings in healthcare aim to improve the overall value of care delivered by reducing unnecessary expenses while maintaining or improving quality outcomes for patients.

Decision-making is the cognitive process of selecting a course of action from among multiple alternatives. In a medical context, decision-making refers to the process by which healthcare professionals and patients make choices about medical tests, treatments, or management options based on a thorough evaluation of available information, including the patient's preferences, values, and circumstances.

The decision-making process in medicine typically involves several steps:

1. Identifying the problem or issue that requires a decision.
2. Gathering relevant information about the patient's medical history, current condition, diagnostic test results, treatment options, and potential outcomes.
3. Considering the benefits, risks, and uncertainties associated with each option.
4. Evaluating the patient's preferences, values, and goals.
5. Selecting the most appropriate course of action based on a careful weighing of the available evidence and the patient's individual needs and circumstances.
6. Communicating the decision to the patient and ensuring that they understand the rationale behind it, as well as any potential risks or benefits.
7. Monitoring the outcomes of the decision and adjusting the course of action as needed based on ongoing evaluation and feedback.

Effective decision-making in medicine requires a thorough understanding of medical evidence, clinical expertise, and patient preferences. It also involves careful consideration of ethical principles, such as respect for autonomy, non-maleficence, beneficence, and justice. Ultimately, the goal of decision-making in healthcare is to promote the best possible outcomes for patients while minimizing harm and respecting their individual needs and values.

'Embryophyta' is a taxonomic group that includes land plants, also known as embryophytes. This group consists of the bryophytes (mosses, liverworts, and hornworts), tracheophytes (vascular plants), and a few extinct plant groups. The defining characteristic of embryophytes is their alternation of generations life cycle, which includes a multicellular diploid sporophyte generation that produces spores through meiosis, and a multicellular haploid gametophyte generation that produces gametes through mitosis. The term 'Embryophyta' is used to distinguish land plants from their algal ancestors, which are classified in separate taxonomic groups.

I'm sorry for any confusion, but "Financial Management" is not a medical term. Financial management refers to the process of managing the financial resources, such as budgeting, investing, raising funds, and planning for an organization or individual. It involves the application of management principles to the financial functions of an organization.

If you have any questions related to medical terminology or concepts, I'd be happy to help with those!

I'm sorry for any confusion, but "Game Theory" is not a medical term. It is actually a mathematical model of strategic interaction, which is commonly used in economics, political science, and psychology. Game theory analyzes how people or entities make decisions when their outcomes depend on the actions of others, and how they can use this knowledge to achieve better results.

In medicine, the term "game" might be used informally to describe various types of simulations or training exercises, but it does not have a specific medical definition related to game theory.

Health policy refers to a set of decisions, plans, and actions that are undertaken to achieve specific healthcare goals within a population. It is formulated by governmental and non-governmental organizations with the objective of providing guidance and direction for the management and delivery of healthcare services. Health policies address various aspects of healthcare, including access, financing, quality, and equity. They can be designed to promote health, prevent disease, and provide treatment and rehabilitation services to individuals who are sick or injured. Effective health policies require careful consideration of scientific evidence, ethical principles, and societal values to ensure that they meet the needs of the population while being fiscally responsible.

I could not find a specific medical definition for "Experimental Games" as it is not a term commonly used in the medical field. However, I can provide some context that might help you understand the possible relationship between experimental games and medicine.

Experimental games generally refer to games designed specifically to explore, test, or validate certain concepts, hypotheses, or theories. These games often involve novel mechanics, rules, or systems that are intended to create unique experiences, engage players in specific ways, or teach particular skills or knowledge.

In the context of medicine and healthcare, experimental games might be used for various purposes, such as:

1. Medical education and training: Experimental games can help medical professionals learn new skills, understand complex concepts, or practice decision-making in a safe, controlled environment. These games could simulate various medical scenarios, allowing players to develop their expertise and improve patient outcomes.
2. Therapeutic interventions: Experimental games might be used as a form of therapy for patients with physical, cognitive, or emotional challenges. By engaging patients in gameplay that targets specific areas of need, these games can help improve various aspects of health and well-being. For example, therapeutic gaming applications have been developed to assist with rehabilitation, pain management, stress reduction, and mental health conditions like anxiety and depression.
3. Research: Experimental games could be used in medical research to investigate various aspects of human behavior, cognition, or physiology. By observing how players interact with the game and its mechanics, researchers can gain insights into factors that influence health, decision-making, or treatment outcomes.

In summary, while "Experimental Games" is not a standard medical term, it generally refers to games designed to explore, test, or validate specific concepts, hypotheses, or theories. In the context of medicine and healthcare, experimental games might be used for medical education, therapeutic interventions, or research purposes.

"Drug costs" refer to the amount of money that must be paid to acquire and use a particular medication. These costs can include the following:

1. The actual purchase price of the drug, which may vary depending on factors such as the dosage form, strength, and quantity of the medication, as well as whether it is obtained through a retail pharmacy, mail-order service, or other distribution channel.
2. Any additional fees or charges associated with obtaining the drug, such as shipping and handling costs, insurance copayments or coinsurance amounts, and deductibles.
3. The cost of any necessary medical services or supplies that are required to administer the drug, such as syringes, needles, or alcohol swabs for injectable medications, or nebulizers for inhaled drugs.
4. The cost of monitoring and managing any potential side effects or complications associated with the use of the drug, which may include additional medical appointments, laboratory tests, or other diagnostic procedures.

It is important to note that drug costs can vary widely depending on a variety of factors, including the patient's insurance coverage, the pharmacy where the drug is obtained, and any discounts or rebates that may be available. Patients are encouraged to shop around for the best prices and to explore all available options for reducing their out-of-pocket costs, such as using generic medications or participating in manufacturer savings programs.

Health Insurance Reimbursement refers to the process of receiving payment from a health insurance company for medical expenses that you have already paid out of pocket. Here is a brief medical definition of each term:

1. Insurance: A contract, represented by a policy, in which an individual or entity receives financial protection or reimbursement against losses from an insurance company. The company pools clients' risks to make payments more affordable for the insured.
2. Health: Refers to the state of complete physical, mental, and social well-being, and not merely the absence of disease or infirmity.
3. Reimbursement: The act of refunding or compensating a person for expenses incurred, especially those that have been previously paid by the individual and are now being paid back by an insurance company.

In the context of health insurance, reimbursement typically occurs when you receive medical care, pay the provider, and then submit a claim to your insurance company for reimbursement. The insurance company will review the claim, determine whether the services are covered under your policy, and calculate the amount they will reimburse you based on your plan's benefits and any applicable co-pays, deductibles, or coinsurance amounts. Once this process is complete, the insurance company will issue a payment to you to cover a portion or all of the costs you incurred for the medical services.

I'm sorry for any confusion, but "Models, Econometric" is not a medical term. Econometric models are statistical tools used in the field of economics to estimate economic relationships and forecast future outcomes. They are based on economic theory and use historical data to estimate the parameters of mathematical equations that describe these relationships.

If you have any questions about medical terms or concepts, I'd be happy to try to help! Just let me know what you're looking for.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

The Health Care Sector is a segment of the economy that includes companies and organizations that provide goods and services to treat patients with medical conditions, as well as those that work to maintain people's health through preventative care and health education. This sector includes hospitals, clinics, physician practices, dental practices, pharmacies, home health care agencies, nursing homes, laboratories, and medical device manufacturers, among others.

The Health Care Sector is often broken down into several subsectors, including:

1. Providers of healthcare services, such as hospitals, clinics, and physician practices.
2. Payers of healthcare costs, such as insurance companies and government agencies like Medicare and Medicaid.
3. Manufacturers of healthcare products, such as medical devices, pharmaceuticals, and biotechnology products.
4. Distributors of healthcare products, such as wholesalers and pharmacy benefit managers.
5. Providers of healthcare information technology, such as electronic health record systems and telemedicine platforms.

The Health Care Sector is a significant contributor to the economy in many countries, providing employment opportunities and contributing to economic growth. However, it also faces significant challenges, including rising costs, an aging population, and increasing demands for access to high-quality care.

Capital expenditures, also known as capital expenses or CapEx, refer to the funds used by a company to acquire, upgrade, and maintain physical assets such as property, buildings, machinery, and equipment. These expenditures are considered long-term investments and are intended to enhance the company's ability to generate future revenue and profits.

Capital expenditures are typically significant in amount and are recorded on a company's balance sheet as assets, rather than being expensed immediately on the income statement. Instead, the cost of these assets is gradually expensed over their useful life through depreciation or amortization.

Examples of capital expenditures include purchasing new manufacturing equipment, constructing a new building, renovating an existing facility, or upgrading computer systems and software. These types of expenses are often necessary for a company to remain competitive and grow its business over time.

Hospital costs are the total amount of money that is expended by a hospital to provide medical and healthcare services to patients. These costs can include expenses related to:

* Hospital staff salaries and benefits
* Supplies, such as medications, medical devices, and surgical equipment
* Utilities, such as electricity, water, and heating
* Facility maintenance and renovation
* Equipment maintenance and purchase
* Administrative costs, such as billing and insurance processing

Hospital costs can also be classified into fixed and variable costs. Fixed costs are those that do not change with the volume of services provided, such as rent or depreciation of equipment. Variable costs are those that change with the volume of services provided, such as supplies and medications.

It's important to note that hospital costs can vary widely depending on factors such as the complexity of care provided, the geographic location of the hospital, and the patient population served. Additionally, hospital costs may not always align with charges or payments for healthcare services, which can be influenced by factors such as negotiated rates with insurance companies and government reimbursement policies.

Voluntary hospitals, also known as non-profit or private hospitals, are medical institutions that are privately owned and operated, typically by a charitable organization or community group. They are called "voluntary" because they are not run by the government and rely on donations, grants, and other forms of financial support from the community to operate.

Voluntary hospitals can be religious or secular in nature and often have a mission to serve specific populations or provide care for underserved communities. They may offer a range of medical services, including emergency care, inpatient and outpatient care, diagnostic testing, and specialized treatments.

These hospitals are typically governed by a board of directors made up of community members and are required to operate on a non-profit basis, meaning that any revenue generated must be reinvested into the hospital's operations or mission rather than distributed to shareholders or owners. Voluntary hospitals may also receive funding from government sources such as Medicare and Medicaid, but they are not owned or operated by the government.

Choice behavior refers to the selection or decision-making process in which an individual consciously or unconsciously chooses one option over others based on their preferences, values, experiences, and motivations. In a medical context, choice behavior may relate to patients' decisions about their healthcare, such as selecting a treatment option, choosing a healthcare provider, or adhering to a prescribed medication regimen. Understanding choice behavior is essential in shaping health policies, developing patient-centered care models, and improving overall health outcomes.

I'm sorry for any confusion, but "policy making" is not a medical term per se. It refers to the process of formulating or establishing official guidelines or rules, such as public policies or organizational policies, that govern decisions and actions. In the context of healthcare, policy making can refer to the development of guidelines, laws, regulations, and procedures that govern the delivery, financing, and accessibility of medical care and health promotion activities.

Examples of policy making in healthcare include:

* Developing clinical practice guidelines for the management of specific medical conditions
* Establishing reimbursement policies for medical procedures or treatments
* Implementing regulations to ensure patient safety and quality of care
* Creating public health policies to address population health issues, such as tobacco control or obesity prevention.

I'm sorry for any confusion, but "investments" is not a term that has a specific medical definition. It is an economic and financial term that refers to the allocation of resources, usually money, with the expectation of receiving future returns or benefits. This could include purchasing stocks, bonds, real estate, or other assets with the goal of generating income or appreciating in value over time.

If you have any questions related to medical terminology or health-related concepts, I'd be happy to help!

"Cost of Illness" is a medical-economic concept that refers to the total societal cost associated with a specific disease or health condition. It includes both direct and indirect costs. Direct costs are those that can be directly attributed to the illness, such as medical expenses for diagnosis, treatment, rehabilitation, and medications. Indirect costs include productivity losses due to morbidity (reduced efficiency while working) and mortality (lost earnings due to death). Other indirect costs may encompass expenses related to caregiving or special education needs. The Cost of Illness is often used in health policy decision-making, resource allocation, and evaluating the economic impact of diseases on society.

The "delivery of health care" refers to the process of providing medical services, treatments, and interventions to individuals in order to maintain, restore, or improve their health. This encompasses a wide range of activities, including:

1. Preventive care: Routine check-ups, screenings, immunizations, and counseling aimed at preventing illnesses or identifying them at an early stage.
2. Diagnostic services: Tests and procedures used to identify and understand medical conditions, such as laboratory tests, imaging studies, and biopsies.
3. Treatment interventions: Medical, surgical, or therapeutic treatments provided to manage acute or chronic health issues, including medications, surgeries, physical therapy, and psychotherapy.
4. Acute care services: Short-term medical interventions focused on addressing immediate health concerns, such as hospitalizations for infections, injuries, or complications from medical conditions.
5. Chronic care management: Long-term care and support provided to individuals with ongoing medical needs, such as those living with chronic diseases like diabetes, heart disease, or cancer.
6. Rehabilitation services: Programs designed to help patients recover from illnesses, injuries, or surgeries, focusing on restoring physical, cognitive, and emotional function.
7. End-of-life care: Palliative and hospice care provided to individuals facing terminal illnesses, with an emphasis on comfort, dignity, and quality of life.
8. Public health initiatives: Population-level interventions aimed at improving community health, such as disease prevention programs, health education campaigns, and environmental modifications.

The delivery of health care involves a complex network of healthcare professionals, institutions, and systems working together to ensure that patients receive the best possible care. This includes primary care physicians, specialists, nurses, allied health professionals, hospitals, clinics, long-term care facilities, and public health organizations. Effective communication, coordination, and collaboration among these stakeholders are essential for high-quality, patient-centered care.

Consummatory behavior refers to the specific, targeted actions that an organism takes in order to obtain a reward or satisfy a physiological need. In the context of human medicine and psychology, consummatory behavior is often used to describe the way that individuals engage with substances or activities that bring them pleasure or satisfaction, such as eating food or using drugs.

In the case of eating, consummatory behavior might refer to the specific actions involved in seeking out, obtaining, and consuming food. This could include things like searching for food, preparing it, and then actually eating it. In the context of drug use, consummatory behavior might refer to the specific actions involved in obtaining and using drugs, such as seeking out a dealer, purchasing drugs, and then using them.

Consummatory behavior is an important concept in medicine and psychology because it can help researchers and clinicians understand why individuals engage in certain behaviors, and how those behaviors might be influenced by factors like physiological needs, environmental cues, and individual preferences. By studying consummatory behavior, researchers may be able to develop more effective interventions for addressing problematic behaviors like substance abuse or disordered eating.

Health care rationing refers to the deliberate limitation or restriction of medical services, treatments, or resources provided to patients based on specific criteria or guidelines. These limitations can be influenced by various factors such as cost-effectiveness, scarcity of resources, evidence-based medicine, and clinical appropriateness. The primary goal of health care rationing is to ensure fair distribution and allocation of finite medical resources among a population while maximizing overall health benefits and minimizing harm.

Rationing can occur at different levels within the healthcare system, including individual patient care decisions, insurance coverage policies, and governmental resource allocation. Examples of rationing include prioritizing certain treatments based on their proven effectiveness, restricting access to high-cost procedures with limited clinical benefits, or setting age limits for specific interventions.

It is important to note that health care rationing remains a controversial topic due to ethical concerns about potential disparities in care and the balance between individual patient needs and societal resource constraints.

Resource allocation in a medical context refers to the process of distributing and managing healthcare resources, such as budget, staff, equipment, and supplies, in an efficient and equitable manner to meet the health needs of a population. This involves prioritizing the use of resources to maximize benefits, improve patient outcomes, and ensure fair access to healthcare services. It is a critical aspect of healthcare planning and management, particularly in situations where resources are limited or there are competing demands for them.

"Drug and narcotic control" refers to the regulation and oversight of drugs and narcotics, including their production, distribution, and use. This is typically carried out by governmental agencies in order to ensure public safety, prevent abuse and diversion, and protect the health of individuals. The goal of drug and narcotic control is to strike a balance between making sure that medications are available for legitimate medical purposes while also preventing their misuse and illegal sale.

Drug control policies may include measures such as licensing and registration of manufacturers, distributors, and pharmacies; tracking and monitoring of controlled substances; setting standards for prescription practices; and enforcement of laws and regulations related to drug use and trafficking. Narcotic control specifically refers to the regulation of drugs that have a high potential for abuse and are subject to international treaties, such as opioids.

It's important to note that while these regulations aim to protect public health and safety, they can also be controversial and have unintended consequences, such as contributing to drug shortages or creating barriers to access for people who need controlled substances for legitimate medical reasons.

Quality-Adjusted Life Years (QALYs) is a measure of health outcomes that combines both the quality and quantity of life lived in a single metric. It is often used in economic evaluations of healthcare interventions to estimate their value for money. QALYs are calculated by multiplying the number of years of life gained by a weighting factor that reflects the quality of life experienced during those years, typically on a scale from 0 (representing death) to 1 (representing perfect health). For example, if a healthcare intervention extends a person's life by an additional five years but they experience only 80% of full health during that time, the QALY gain would be 4 (5 x 0.8). This measure allows for comparisons to be made between different interventions and their impact on both length and quality of life.

Urological agents are a category of pharmaceuticals that are used to treat various conditions related to the urinary system. These medications can be used to manage symptoms or to treat underlying causes of urological disorders. The specific type of urological agent used will depend on the particular condition being treated, and may include:

* Anticholinergic agents: Used to treat overactive bladder by relaxing the muscles of the bladder.
* Alpha-blockers: Used to treat an enlarged prostate (benign prostatic hyperplasia) by relaxing the muscles around the urethra, making it easier to urinate.
* 5-alpha-reductase inhibitors: Also used to treat an enlarged prostate, these medications work by shrinking the prostate gland over time.
* Antibiotics: Used to treat urinary tract infections and other types of bacterial infections that can affect the urinary system.
* Analgesics: Used to relieve pain associated with urological conditions such as kidney stones or interstitial cystitis.
* Botulinum toxin (Botox): Injected into the bladder muscle to treat overactive bladder and reduce urinary incontinence.

It's important to note that these are just a few examples of urological agents, and there are many other medications available depending on the specific condition being treated. It is essential to consult with a healthcare provider for proper diagnosis and treatment.

Audiovisual aids are educational tools that utilize both visual and auditory senses to facilitate learning and communication. These aids can include various forms of technology such as projectors, televisions, computers, and mobile devices, as well as traditional materials like posters, charts, and models. In a medical context, audiovisual aids may be used in lectures, presentations, or patient education to help illustrate complex concepts, demonstrate procedures, or provide information in a clear and engaging way. They can be particularly useful for individuals who learn best through visual or auditory means, and can help to improve comprehension and retention of information.

Fees and charges in a medical context refer to the costs that patients are required to pay for healthcare services, treatments, or procedures. These may include:

1. Professional fees: The amount charged by healthcare professionals such as doctors, nurses, or therapists for their time, expertise, and services provided during consultations, examinations, or treatments.

2. Hospital charges: The costs associated with a patient's hospital stay, including room and board, nursing care, medications, and diagnostic tests.

3. Facility fees: Additional charges levied by hospitals, clinics, or ambulatory surgery centers to cover the overhead expenses of maintaining the facility and its equipment.

4. Procedure or treatment-specific fees: Costs directly related to specific medical procedures, surgeries, or treatments, such as anesthesia, radiology services, laboratory tests, or surgical supplies.

5. Ancillary fees: Additional costs for items like crutches, slings, or durable medical equipment that patients may need during their recovery process.

6. Insurance copayments, coinsurance, and deductibles: The portion of healthcare expenses that patients are responsible for paying based on their insurance policy terms.

It is essential for patients to understand the fees and charges associated with their medical care to make informed decisions about their treatment options and manage their healthcare costs effectively.

I'm sorry for any confusion, but "social values" is not a term that has a specific medical definition. However, in a broader social context, "social values" refer to the beliefs, principles, and standards that a group or society holds in regard to what is considered important, desirable, or acceptable. These values can influence attitudes, behaviors, and decisions related to health and healthcare. They may also impact medical research, policy-making, and patient care.

Neurosciences is a multidisciplinary field of study that focuses on the structure, function, development, and disorders of the nervous system, which includes the brain, spinal cord, and peripheral nerves. It incorporates various scientific disciplines such as biology, chemistry, physics, mathematics, engineering, and computer science to understand the complexities of the nervous system at different levels, from molecular and cellular mechanisms to systems and behavior.

The field encompasses both basic research and clinical applications, with the aim of advancing our knowledge of the nervous system and developing effective treatments for neurological and psychiatric disorders. Specialties within neurosciences include neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, neurobiology, neuroimmunology, behavioral neuroscience, cognitive neuroscience, clinical neuroscience, and computational neuroscience, among others.

Cost allocation is the process of distributing or assigning costs to different departments, projects, products, or services within an organization. The goal of cost allocation is to more accurately determine the true cost of producing a product or providing a service, taking into account all related expenses. This can help organizations make better decisions about pricing, resource allocation, and profitability analysis.

There are various methods for allocating costs, including activity-based costing (ABC), which assigns costs based on the activities required to produce a product or provide a service; traditional costing, which uses broad categories such as direct labor, direct materials, and overhead; and causal allocation, which assigns costs based on a specific cause-and-effect relationship.

In healthcare, cost allocation is particularly important for determining the true cost of patient care, including both direct and indirect costs. This can help hospitals and other healthcare organizations make informed decisions about resource allocation, pricing, and reimbursement strategies.

I must clarify that I'm a helpful assistant and not a doctor, but I can tell you that 'politics' is not a term used in medicine. Politics refers to the activities associated with the governance of a country or area, especially the debate or conflict among individuals or groups having or hoping to achieve power. If you have any medical questions, feel free to ask!

I'm happy to help! However, it's important to note that while "social justice" is a term used in many fields, including public health and medicine, it does not have a single, universally accepted medical definition. Instead, the concept of social justice in healthcare is generally understood as the pursuit of fairness, equity, and equality in the distribution of healthcare resources, opportunities, and outcomes.

The World Health Organization (WHO) defines social justice as "the fair and equitable distribution of social determinants of health, which are conditions in which people are born, grow, live, work, and age, including the health system." According to this definition, social justice in healthcare requires addressing the root causes of health disparities, such as poverty, discrimination, and lack of access to education and employment opportunities.

The American Public Health Association (APHA) defines social justice as "the distribution of resources, benefits, and burdens of society to all individuals and groups. When principles of social justice are applied, the resulting distribution is equitable and all members of society have a fair opportunity to benefit from the resources, benefits, and burdens."

In summary, while there may not be a single medical definition of social justice, it is generally understood as the pursuit of fairness, equity, and equality in healthcare and health outcomes. This involves addressing the root causes of health disparities and ensuring that all individuals have access to the resources and opportunities they need to achieve optimal health.

"Public policy" is not a medical term, but rather a term used in the field of politics, government, and public administration. It refers to a course or principle of action adopted or proposed by a government, party, business, or organization to guide decisions and achieve specific goals related to public health, safety, or welfare.

However, in the context of healthcare and medicine, "public policy" often refers to laws, regulations, guidelines, and initiatives established by government entities to promote and protect the health and well-being of the population. Public policies in healthcare aim to ensure access to quality care, reduce health disparities, promote public health, regulate healthcare practices and industries, and address broader social determinants of health. Examples include Medicaid and Medicare programs, laws mandating insurance coverage for certain medical procedures or treatments, and regulations governing the safety and efficacy of drugs and medical devices.

I'm sorry for any confusion, but "Taxes" is not a medical term. It refers to a compulsory financial charge or levy imposed on individuals or entities by a governmental authority to fund various public expenditures and services. If you have any medical questions or terms you would like defined, I'd be happy to help!

I'm sorry for any confusion, but "technology" is a broad term that refers to the application of scientific knowledge for practical purposes, especially in industry. It's not something that typically has a medical definition, as it's not a medical term or concept. However, in the context of healthcare, "health technology" is a term used to refer to the application of technology in healthcare, such as medical devices, electronic health records, telemedicine platforms, and other tools that are used to prevent, diagnose, or treat medical conditions.

I'm sorry for any confusion, but "Social Sciences" is a broad term that refers to academic disciplines that study human society and social relationships. It includes fields such as anthropology, sociology, psychology, political science, and economics. These subjects are considered part of the liberal arts and humanities, not medical sciences.

However, aspects of social sciences can intersect with medical studies in areas like medical anthropology, health psychology, sociology of health and illness, and psychiatry. For instance, medical anthropologists might study how cultural factors influence healthcare practices, while health psychologists examine the role of behavior and mental processes in health and illness.

If you're looking for a definition related to medical sciences, perhaps there was some confusion with the term. Could you please clarify or provide more context?

Public health is defined by the World Health Organization (WHO) as "the art and science of preventing disease, prolonging life and promoting human health through organized efforts of society." It focuses on improving the health and well-being of entire communities, populations, and societies, rather than individual patients. This is achieved through various strategies, including education, prevention, surveillance of diseases, and promotion of healthy behaviors and environments. Public health also addresses broader determinants of health, such as access to healthcare, housing, food, and income, which have a significant impact on the overall health of populations.

Direct service costs are expenses that can be directly attributed to the delivery of a specific service or program. These costs are typically related to items such as personnel, supplies, and equipment that are used exclusively for the provision of that service. Direct service costs can be contrasted with indirect costs, which are expenses that are not easily linked to a particular service or program and may include things like administrative overhead, rent, and utilities.

Examples of direct service costs in a healthcare setting might include:

* Salaries and benefits for medical staff who provide patient care, such as doctors, nurses, and therapists
* Costs of medications and supplies used to treat patients
* Equipment and supplies needed to perform diagnostic tests or procedures, such as X-ray machines or surgical instruments
* Rent or lease payments for space that is dedicated to providing patient care services.

It's important to accurately track direct service costs in order to understand the true cost of delivering a particular service or program, and to make informed decisions about resource allocation and pricing.

Altruism is a term used in the medical and psychological fields to describe selfless behavior that is done with the intention of benefiting another person, often at the expense or risk of the person performing the act. Altruistic behaviors can include a wide range of actions, from small acts of kindness to more significant sacrifices, such as donating an organ to save the life of someone else.

Altruism is often motivated by feelings of empathy and compassion for others, and it can have positive effects on both the giver and the recipient. Research has shown that engaging in altruistic behaviors can improve mental health and well-being, reduce stress, and even increase lifespan.

While altruism is often viewed as a positive trait, there is some debate among psychologists and philosophers about whether true altruism exists, or if all acts of kindness are ultimately motivated by self-interest. Nonetheless, the concept of altruism remains an important one in medicine and psychology, as it helps to explain why people sometimes act in ways that put others' needs before their own.

"World Health" is not a term that has a specific medical definition. However, it is often used in the context of global health, which can be defined as:

"The area of study, research and practice that places a priority on improving health and achieving equity in health for all people worldwide. It emphasizes trans-national health issues, determinants, and solutions; involves many disciplines within and beyond the health sciences and engages stakeholders from across sectors and societies." (World Health Organization)

Therefore, "world health" could refer to the overall health status and health challenges faced by populations around the world. It encompasses a broad range of factors that affect the health of individuals and communities, including social, economic, environmental, and political determinants. The World Health Organization (WHO) plays a key role in monitoring and promoting global health, setting international standards and guidelines, and coordinating responses to global health emergencies.

Animal husbandry is the practice of breeding and raising animals for agricultural purposes, such as for the production of meat, milk, eggs, or fiber. It involves providing proper care for the animals, including feeding, housing, health care, and breeding management. The goal of animal husbandry is to maintain healthy and productive animals while also being mindful of environmental sustainability and animal welfare.

I'm sorry for any confusion, but the term "Great Britain" is not a medical concept or condition. It is a geographical and political term referring to the largest island in the British Isles, on which the majority of England, Scotland, and Wales are located. It's also used to refer to the political union of these three countries, which is called the United Kingdom. Therefore, it doesn't have a medical definition.

The term "Theoretical Models" is used in various scientific fields, including medicine, to describe a representation of a complex system or phenomenon. It is a simplified framework that explains how different components of the system interact with each other and how they contribute to the overall behavior of the system. Theoretical models are often used in medical research to understand and predict the outcomes of diseases, treatments, or public health interventions.

A theoretical model can take many forms, such as mathematical equations, computer simulations, or conceptual diagrams. It is based on a set of assumptions and hypotheses about the underlying mechanisms that drive the system. By manipulating these variables and observing the effects on the model's output, researchers can test their assumptions and generate new insights into the system's behavior.

Theoretical models are useful for medical research because they allow scientists to explore complex systems in a controlled and systematic way. They can help identify key drivers of disease or treatment outcomes, inform the design of clinical trials, and guide the development of new interventions. However, it is important to recognize that theoretical models are simplifications of reality and may not capture all the nuances and complexities of real-world systems. Therefore, they should be used in conjunction with other forms of evidence, such as experimental data and observational studies, to inform medical decision-making.

In the context of medicine, uncertainty refers to a state of having limited knowledge or awareness about a specific medical condition, diagnosis, prognosis, treatment, or outcome in a patient. It is a common experience for healthcare professionals when making decisions due to the complexity and variability of human health and disease processes. Uncertainty can arise from various sources, such as:

1. Incomplete or ambiguous information about the patient's medical history, symptoms, examination findings, or diagnostic test results.
2. Limited scientific evidence supporting specific diagnostic or therapeutic approaches.
3. Discrepancies between different sources of information or conflicting expert opinions.
4. Variability in patients' responses to treatments and their individual preferences and values.
5. Rapidly evolving medical knowledge and technology, which can make it challenging for healthcare professionals to stay up-to-date.

Uncertainty is an inherent aspect of medical practice, and managing it effectively is crucial for providing high-quality patient care. Healthcare professionals need to communicate uncertainty openly with their patients, involve them in shared decision-making processes, and seek additional information or consultation when necessary. Embracing uncertainty can also foster curiosity, learning, and innovation in the medical field.

I apologize for any confusion, but "Teaching Materials" is not a medical term or concept. It generally refers to resources and tools used by educators to facilitate learning, which can include textbooks, multimedia presentations, handouts, and other materials used in educational settings. If you have a specific term related to medicine or healthcare in mind, please let me know so I can provide a more accurate definition.

Research, in the context of medicine, is a systematic and rigorous process of collecting, analyzing, and interpreting information in order to increase our understanding, develop new knowledge, or evaluate current practices and interventions. It can involve various methodologies such as observational studies, experiments, surveys, or literature reviews. The goal of medical research is to advance health care by identifying new treatments, improving diagnostic techniques, and developing prevention strategies. Medical research is typically conducted by teams of researchers including clinicians, scientists, and other healthcare professionals. It is subject to ethical guidelines and regulations to ensure that it is conducted responsibly and with the best interests of patients in mind.

Health care reform refers to the legislative efforts, initiatives, and debates aimed at improving the quality, affordability, and accessibility of health care services. These reforms may include changes to health insurance coverage, delivery systems, payment methods, and healthcare regulations. The goals of health care reform are often to increase the number of people with health insurance, reduce healthcare costs, and improve the overall health outcomes of a population. Examples of notable health care reform measures in the United States include the Affordable Care Act (ACA) and Medicare for All proposals.

Herd immunity, also known as community immunity or population immunity, is a form of indirect protection from infectious diseases that occurs when a large percentage of a population has become immune to an infection, either through vaccination or previous illness. This reduces the likelihood of infection for individuals who are not immune, especially those who cannot receive vaccines due to medical reasons. The more people in a community who are immune, the less likely the disease will spread and the entire community is protected, not just those who are immune.

Health services research (HSR) is a multidisciplinary field of scientific investigation that studies how social factors, financing systems, organizational structures and processes, health technologies, and personal behaviors affect access to healthcare, the quality and cost of care, and ultimately, our health and well-being. The goal of HSR is to inform policy and practice, improve system performance, and enhance the health and well-being of individuals and communities. It involves the use of various research methods, including epidemiology, biostatistics, economics, sociology, management science, political science, and psychology, to answer questions about the healthcare system and how it can be improved.

Examples of HSR topics include:

* Evaluating the effectiveness and cost-effectiveness of different healthcare interventions and technologies
* Studying patient-centered care and patient experiences with the healthcare system
* Examining healthcare workforce issues, such as shortages of primary care providers or the impact of nurse-to-patient ratios on patient outcomes
* Investigating the impact of health insurance design and financing systems on access to care and health disparities
* Analyzing the organization and delivery of healthcare services in different settings, such as hospitals, clinics, and long-term care facilities
* Identifying best practices for improving healthcare quality and safety, reducing medical errors, and eliminating wasteful or unnecessary care.

Nutritional Sciences is a field of study that deals with the scientific examination and understanding of nutrients in food, how the body uses them, and the relationship between diet, health, and disease. It encompasses various disciplines including biochemistry, physiology, molecular biology, epidemiology, and clinical nutrition.

The field covers several key areas such as:

1. Nutrient metabolism: This involves studying how nutrients are digested, absorbed, transported, stored, and utilized in the body for energy production, growth, maintenance, and reproduction.
2. Diet and disease prevention: Nutritional sciences investigate the role of diet in preventing or managing various health conditions like obesity, diabetes, cardiovascular diseases, and cancer.
3. Functional foods and nutraceuticals: This area focuses on studying the potential health benefits of specific foods or food components beyond their basic nutritional value, including functional foods (foods that have demonstrated health benefits) and nutraceuticals (nutrient-rich supplements derived from food sources).
4. Public health nutrition: Nutritional sciences also address population-wide nutrition issues, such as malnutrition, food insecurity, and the development of public policies related to food and health.
5. Clinical nutrition: This subfield applies nutritional principles and research findings to patient care, focusing on developing individualized dietary plans for patients with various medical conditions.

Overall, Nutritional Sciences aims to provide a solid scientific foundation for making informed dietary choices and promoting optimal health outcomes across populations and individuals.

Social behavior, in the context of medicine and psychology, refers to the ways in which individuals interact and engage with others within their social environment. It involves various actions, communications, and responses that are influenced by cultural norms, personal values, emotional states, and cognitive processes. These behaviors can include but are not limited to communication, cooperation, competition, empathy, altruism, aggression, and conformity.

Abnormalities in social behavior may indicate underlying mental health conditions such as autism spectrum disorder, schizophrenia, or personality disorders. Therefore, understanding and analyzing social behavior is an essential aspect of diagnosing and treating various psychological and psychiatric conditions.

Health promotion is the process of enabling people to increase control over their health and its determinants, and to improve their health. It moves beyond a focus on individual behavior change to include social and environmental interventions that can positively influence the health of individuals, communities, and populations. Health promotion involves engaging in a wide range of activities, such as advocacy, policy development, community organization, and education that aim to create supportive environments and personal skills that foster good health. It is based on principles of empowerment, participation, and social justice.

Health expenditures refer to the total amount of money spent on health services, goods, and resources in a given period. This can include expenses for preventive care, medical treatments, medications, long-term care, and administrative costs. Health expenditures can be made by individuals, corporations, insurance companies, or governments, and they can be measured at the national, regional, or household level.

Health expenditures are often used as an indicator of a country's investment in its healthcare system and can reflect the overall health status of a population. High levels of health expenditures may indicate a strong commitment to healthcare, but they can also place a significant burden on individuals, businesses, and governments. Understanding patterns and trends in health expenditures is important for policymakers, healthcare providers, and researchers who are working to improve the efficiency, effectiveness, and accessibility of healthcare services.

'Behavior' is a term used in the medical and scientific community to describe the actions or reactions of an individual in response to internal or external stimuli. It can be observed and measured, and it involves all the responses of a person, including motor responses, emotional responses, and cognitive responses. Behaviors can be voluntary or involuntary, adaptive or maladaptive, and normal or abnormal. They can also be influenced by genetic, physiological, environmental, and social factors. In a medical context, the study of behavior is often relevant to understanding and treating various mental health conditions, such as anxiety disorders, mood disorders, and personality disorders.

The term "developing countries" is a socio-economic classification used to describe nations that are in the process of industrialization and modernization. This term is often used interchangeably with "low and middle-income countries" or "Global South." The World Bank defines developing countries as those with a gross national income (GNI) per capita of less than US $12,695.

In the context of healthcare, developing countries face unique challenges including limited access to quality medical care, lack of resources and infrastructure, high burden of infectious diseases, and a shortage of trained healthcare professionals. These factors contribute to significant disparities in health outcomes between developing and developed nations.

Interdisciplinary communication in a medical context refers to the exchange of information and ideas between professionals from different healthcare disciplines, such as doctors, nurses, pharmacists, social workers, and therapists. This form of communication is essential for coordinating patient care, making informed treatment decisions, and ensuring that all members of the healthcare team are aware of the patient's needs, goals, and progress. Effective interdisciplinary communication can help to improve patient outcomes, increase patient satisfaction, and reduce medical errors. It typically involves clear, concise, and respectful communication, often through regular meetings, shared documentation, and collaborative decision-making processes.

A medical definition of 'food' would be:

"Substances consumed by living organisms, usually in the form of meals, which contain necessary nutrients such as carbohydrates, proteins, fats, vitamins, minerals, and water. These substances are broken down during digestion to provide energy, build and repair tissues, and regulate bodily functions."

It's important to note that while this is a medical definition, it also aligns with common understanding of what food is.

A bibliographic database is a type of database that contains records of publications, such as books, articles, and conference proceedings. These records typically include bibliographic information, such as the title, author, publication date, and source of the publication. Some bibliographic databases also include abstracts or summaries of the publications, and many provide links to the full text of the publications if they are available online.

Bibliographic databases are used in a variety of fields, including academia, medicine, and industry, to locate relevant publications on a particular topic. They can be searched using keywords, author names, and other criteria. Some bibliographic databases are general, covering a wide range of topics, while others are specialized and focus on a specific subject area.

In the medical field, bibliographic databases such as MEDLINE and PubMed are widely used to search for articles related to biomedical research, clinical practice, and public health. These databases contain records of articles from thousands of biomedical journals and can be searched using keywords, MeSH (Medical Subject Headings) terms, and other criteria.

A reinforcement schedule is a concept in behavioral psychology that refers to the timing and pattern of rewards or reinforcements provided in response to certain behaviors. It is used to shape, maintain, or strengthen specific behaviors in individuals. There are several types of reinforcement schedules, including:

1. **Fixed Ratio (FR):** A reward is given after a fixed number of responses. For example, a salesperson might receive a bonus for every 10 sales they make.
2. **Variable Ratio (VR):** A reward is given after an unpredictable number of responses. This schedule is commonly used in gambling, as the uncertainty of when a reward (winning) will occur keeps the individual engaged and motivated to continue the behavior.
3. **Fixed Interval (FI):** A reward is given after a fixed amount of time has passed since the last reward, regardless of the number of responses during that time. For example, an employee might receive a paycheck every two weeks, regardless of how many tasks they completed during that period.
4. **Variable Interval (VI):** A reward is given after an unpredictable amount of time has passed since the last reward, regardless of the number of responses during that time. This schedule can be observed in foraging behavior, where animals search for food at irregular intervals.
5. **Combined schedules:** Reinforcement schedules can also be combined to create more complex patterns, such as a fixed ratio followed by a variable interval (FR-VI) or a variable ratio followed by a fixed interval (VR-FI).

Understanding reinforcement schedules is essential for developing effective behavioral interventions in various settings, including healthcare, education, and rehabilitation.

Health Priorities are key areas of focus in healthcare that receive the greatest attention, resources, and efforts due to their significant impact on overall population health. These priorities are typically determined by evaluating various health issues and factors such as prevalence, severity, mortality rates, and social determinants of health. By addressing health priorities, healthcare systems and public health organizations aim to improve community health, reduce health disparities, and enhance the quality of life for individuals. Examples of health priorities may include chronic diseases (such as diabetes or heart disease), mental health, infectious diseases, maternal and child health, injury prevention, and health promotion through healthy lifestyles.

"Review literature" is a term used to describe a type of scientific or academic writing that summarizes and synthesizes existing research on a particular topic. A review literature article, also known as a literature review, provides an overview of the current state of knowledge on a subject, highlighting the most important studies, methods, findings, and controversies.

A well-conducted review literature article is based on a thorough and systematic search of the relevant scientific or academic databases, journals, and other sources of information. The selection of studies for inclusion in the review is typically based on specific criteria, such as the quality of the research design, the relevance of the findings to the topic, and the publication date.

The purpose of a review literature article is to provide a critical analysis of the existing research, identify gaps in the current knowledge, and suggest directions for future research. It can also serve as a guide for researchers, clinicians, policymakers, and other stakeholders who are interested in staying up-to-date with the latest developments in their field.

In medical contexts, review literature articles are often used to inform evidence-based practice, clinical guidelines, and health policy decisions. They can also help to identify research priorities and guide funding agencies in allocating resources for future studies.

Interpersonal relations, in the context of medicine and healthcare, refer to the interactions and relationships between patients and healthcare professionals, as well as among healthcare professionals themselves. These relationships are crucial in the delivery of care and can significantly impact patient outcomes. Positive interpersonal relations can lead to improved communication, increased trust, greater patient satisfaction, and better adherence to treatment plans. On the other hand, negative or strained interpersonal relations can result in poor communication, mistrust, dissatisfaction, and non-adherence.

Healthcare professionals are trained to develop effective interpersonal skills, including active listening, empathy, respect, and cultural sensitivity, to build positive relationships with their patients. Effective interpersonal relations also involve clear and concise communication, setting appropriate boundaries, and managing conflicts in a constructive manner. In addition, positive interpersonal relations among healthcare professionals can promote collaboration, teamwork, and knowledge sharing, leading to improved patient care and safety.

In the context of healthcare and medical psychology, motivation refers to the driving force behind an individual's goal-oriented behavior. It is the internal or external stimuli that initiate, direct, and sustain a person's actions towards achieving their desired outcomes. Motivation can be influenced by various factors such as biological needs, personal values, emotional states, and social contexts.

In clinical settings, healthcare professionals often assess patients' motivation to engage in treatment plans, adhere to medical recommendations, or make lifestyle changes necessary for improving their health status. Enhancing a patient's motivation can significantly impact their ability to manage chronic conditions, recover from illnesses, and maintain overall well-being. Various motivational interviewing techniques and interventions are employed by healthcare providers to foster intrinsic motivation and support patients in achieving their health goals.

Psychological models are theoretical frameworks used in psychology to explain and predict mental processes and behaviors. They are simplified representations of complex phenomena, consisting of interrelated concepts, assumptions, and hypotheses that describe how various factors interact to produce specific outcomes. These models can be quantitative (e.g., mathematical equations) or qualitative (e.g., conceptual diagrams) in nature and may draw upon empirical data, theoretical insights, or both.

Psychological models serve several purposes:

1. They provide a systematic and organized way to understand and describe psychological phenomena.
2. They generate hypotheses and predictions that can be tested through empirical research.
3. They integrate findings from different studies and help synthesize knowledge across various domains of psychology.
4. They inform the development of interventions and treatments for mental health disorders.

Examples of psychological models include:

1. The Five Factor Model (FFM) of personality, which posits that individual differences in personality can be described along five broad dimensions: Openness, Conscientiousness, Extraversion, Agreeableness, and Neuroticism.
2. The Cognitive-Behavioral Therapy (CBT) model, which suggests that maladaptive thoughts, feelings, and behaviors are interconnected and can be changed through targeted interventions.
3. The Dual Process Theory of Attitudes, which proposes that attitudes are formed and influenced by two distinct processes: a rapid, intuitive process (heuristic) and a slower, deliberative process (systematic).
4. The Social Cognitive Theory, which emphasizes the role of observational learning, self-efficacy, and outcome expectations in shaping behavior.
5. The Attachment Theory, which describes the dynamics of long-term relationships between humans, particularly the parent-child relationship.

It is important to note that psychological models are provisional and subject to revision or replacement as new evidence emerges. They should be considered as useful tools for understanding and explaining psychological phenomena rather than definitive truths.

Evidence-Based Medicine (EBM) is a medical approach that combines the best available scientific evidence with clinical expertise and patient values to make informed decisions about diagnosis, treatment, and prevention of diseases. It emphasizes the use of systematic research, including randomized controlled trials and meta-analyses, to guide clinical decision making. EBM aims to provide the most effective and efficient care while minimizing variations in practice, reducing errors, and improving patient outcomes.

Organizational decision-making is a management process in which a group or team within an organization makes a judgment or choice among several options or alternatives to achieve specific goals or objectives. This process involves collecting and analyzing information, evaluating alternatives, selecting the best option, and implementing and monitoring the decision. It often requires collaboration, communication, and consensus-building among team members with diverse perspectives and expertise. Effective organizational decision-making can lead to better outcomes, improved performance, and increased innovation, while poor decision-making can result in missed opportunities, wasted resources, and decreased competitiveness.

The "drug industry" is also commonly referred to as the "pharmaceutical industry." It is a segment of the healthcare sector that involves the research, development, production, and marketing of medications or drugs. This includes both prescription and over-the-counter medicines used to treat, cure, or prevent diseases and medical conditions in humans and animals.

The drug industry comprises various types of organizations, such as:

1. Research-based pharmaceutical companies: These are large corporations that focus on the research and development (R&D) of new drugs, clinical trials, obtaining regulatory approvals, manufacturing, and marketing their products globally. Examples include Pfizer, Johnson & Johnson, Roche, and Merck.

2. Generic drug manufacturers: After the patent for a brand-name drug expires, generic drug manufacturers can produce and sell a similar version of the drug at a lower cost. These companies must demonstrate that their product is bioequivalent to the brand-name drug in terms of safety, quality, and efficacy.

3. Biotechnology companies: These firms specialize in developing drugs using biotechnological methods, such as recombinant DNA technology, gene therapy, or monoclonal antibodies. Many biotech companies focus on specific therapeutic areas, like oncology, immunology, or neurology.

4. Contract research organizations (CROs): CROs provide various services to the drug industry, including clinical trial management, data analysis, regulatory affairs support, and pharmacovigilance. They work with both large pharmaceutical companies and smaller biotech firms to help streamline the drug development process.

5. Drug delivery system companies: These organizations focus on developing innovative technologies for delivering drugs more effectively and safely to patients. Examples include transdermal patches, inhalers, or long-acting injectables.

6. Wholesalers and distributors: Companies that purchase drugs from manufacturers and distribute them to pharmacies, hospitals, and other healthcare providers.

The drug industry plays a crucial role in improving public health by discovering, developing, and delivering new treatments for various diseases and medical conditions. However, it is also subject to criticism and regulation due to concerns about high drug prices, marketing practices, and the potential for conflicts of interest between industry and healthcare professionals.

I'm sorry for any confusion, but "Maryland" is a proper noun and does not have a medical definition. It is a state located in the Mid-Atlantic region of the United States. However, if you are referring to a specific medical term or concept that includes "Maryland," could you please provide more context? I'll do my best to help with accurate information based on the provided context.

The conservation of natural resources refers to the responsible use and management of natural resources, such as water, soil, minerals, forests, and wildlife, in a way that preserves their availability for future generations. This may involve measures such as reducing waste and pollution, promoting sustainable practices, protecting habitats and ecosystems, and engaging in careful planning and decision-making to ensure the long-term sustainability of these resources. The goal of conservation is to balance the needs of the present with the needs of the future, so that current and future generations can continue to benefit from the many goods and services that natural resources provide.

Nutrition disorders refer to conditions that result from eating, drinking, or absorbing nutrients in a way that is not consistent with human physiological needs. These disorders can manifest as both undernutrition and overnutrition. Undernutrition includes disorders such as protein-energy malnutrition, vitamin deficiencies, and mineral deficiencies, while overnutrition includes conditions such as obesity and diet-related noncommunicable diseases like diabetes, cardiovascular disease, and certain types of cancer.

Malnutrition is the broad term used to describe a state in which a person's nutrient intake is insufficient or excessive, leading to negative consequences for their health. Malnutrition can be caused by a variety of factors, including poverty, food insecurity, lack of education, cultural practices, and chronic diseases.

In addition to under- and overnutrition, disordered eating patterns such as anorexia nervosa, bulimia nervosa, binge eating disorder, and other specified feeding or eating disorders can also be considered nutrition disorders. These conditions are characterized by abnormal eating habits that can lead to serious health consequences, including malnutrition, organ damage, and mental health problems.

Overall, nutrition disorders are complex conditions that can have significant impacts on a person's physical and mental health. They require careful assessment, diagnosis, and treatment by healthcare professionals with expertise in nutrition and dietetics.

I'm sorry for any confusion, but "International Cooperation" is not a medical term. It refers to the collaboration and exchange of resources and information between countries or international organizations in various fields, including politics, economics, culture, environment, and security, among others. In the context of healthcare and medicine, international cooperation can involve joint research projects, sharing of data and clinical trial results, collaborative efforts to combat global health issues (such as infectious diseases or chronic conditions), capacity building in low-resource settings, and standardizing medical practices and guidelines across countries.

Cooperative behavior, in a medical or healthcare context, refers to the actions and attitudes displayed by individuals or groups working together to achieve a common goal related to health and well-being. This may involve patients following their healthcare providers' advice, healthcare professionals collaborating to diagnose and treat medical conditions, or communities coming together to promote healthy behaviors and environments. Cooperative behavior is essential for positive health outcomes, as it fosters trust, communication, and shared decision-making between patients and healthcare providers, and helps to ensure that everyone involved in the care process is working towards the same goal.

Impulsive behavior can be defined medically as actions performed without proper thought or consideration of the consequences, driven by immediate needs, desires, or urges. It often involves risky or inappropriate behaviors that may lead to negative outcomes. In a clinical context, impulsivity is frequently associated with certain mental health conditions such as ADHD (Attention Deficit Hyperactivity Disorder), bipolar disorder, borderline personality disorder, and some neurological conditions. It's important to note that everyone can exhibit impulsive behavior at times, but when it becomes a persistent pattern causing distress or functional impairment, it may indicate an underlying condition requiring professional assessment and treatment.

I believe you may have mixed up the terms "medicine" and "commerce." Commerce is a broad term that refers to the buying and selling of goods and services. It is not typically used in a medical context, so it does not have a specific medical definition. However, I can provide you with some related terms that might be helpful:

1. Medical commerce: This term generally refers to the business aspects of healthcare, such as the buying and selling of medical supplies, equipment, and services. It may also refer to the economic relationships between various stakeholders in the healthcare system, including providers, insurers, pharmaceutical companies, and patients.
2. Telemedicine commerce: This term specifically refers to the use of technology to facilitate remote consultations and transactions between healthcare providers and patients. Examples include online appointment scheduling, virtual consultations, and electronic prescribing.
3. Medical tourism: This is a form of commerce where people travel to other countries to receive medical treatment or procedures that may be less expensive or more accessible than in their home country. It can also refer to the business of providing medical services to international patients.
4. Healthcare marketing: This term refers to the activities and strategies used by healthcare organizations to promote their products, services, and brands to potential customers. It includes advertising, public relations, social media, content marketing, and other tactics designed to build awareness, generate leads, and drive sales.

I hope this information is helpful! Let me know if you have any further questions or concerns.

Managed care programs are a type of health insurance plan that aims to control healthcare costs and improve the quality of care by managing the utilization of healthcare services. They do this by using a network of healthcare providers who have agreed to provide services at reduced rates, and by implementing various strategies such as utilization review, case management, and preventive care.

In managed care programs, there is usually a primary care physician (PCP) who acts as the patient's main doctor and coordinates their care within the network of providers. Patients may need a referral from their PCP to see specialists or access certain services. Managed care programs can take various forms, including Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs), Point-of-Service (POS) plans, and Exclusive Provider Organizations (EPOs).

The goal of managed care programs is to provide cost-effective healthcare services while maintaining or improving the quality of care. They can help patients save money on healthcare costs by providing coverage for a range of services at lower rates than traditional fee-for-service plans, but they may also limit patient choice and require prior authorization for certain procedures or treatments.

I'm sorry for any confusion, but the term "Europe" is a geographical and political designation, rather than a medical one. It refers to the continent located entirely in the Northern Hemisphere and mostly in the Eastern Hemisphere. It is bordered by the Arctic Ocean to the north, the Atlantic Ocean to the west, and the Mediterranean Sea to the south. Europe is made up of approximately 50 countries, depending on how one defines a "country."

If you have any questions related to medical terminology or health-related topics, I'd be happy to help answer them!

In the context of medicine, particularly in behavioral neuroscience and psychology, "reward" is not typically used as a definitive medical term. However, it generally refers to a positive outcome or incentive that reinforces certain behaviors, making them more likely to be repeated in the future. This can involve various stimuli such as food, water, sexual activity, social interaction, or drug use, among others.

In the brain, rewards are associated with the activation of the reward system, primarily the mesolimbic dopamine pathway, which includes the ventral tegmental area (VTA) and the nucleus accumbens (NAcc). The release of dopamine in these areas is thought to reinforce and motivate behavior linked to rewards.

It's important to note that while "reward" has a specific meaning in this context, it is not a formal medical diagnosis or condition. Instead, it is a concept used to understand the neural and psychological mechanisms underlying motivation, learning, and addiction.

I apologize, but "Canada" is not a medical term or concept. It is a country located in North America, known for its vast wilderness, multicultural cities, and significant natural resources. If you have any questions related to healthcare or medical terms, I would be happy to help answer those!

"State Medicine" is not a term that has a widely accepted or specific medical definition. However, in general terms, it can refer to the organization, financing, and delivery of healthcare services and resources at the national or regional level, overseen and managed by the government or state. This can include public health initiatives, regulation of healthcare professionals and institutions, and the provision of healthcare services through publicly funded programs.

In some contexts, "State Medicine" may also refer to the practice of using medical treatments or interventions as a means of achieving political or social objectives, such as reducing crime rates or improving economic productivity. However, this usage is less common and more controversial.

Program Evaluation is a systematic and objective assessment of a healthcare program's design, implementation, and outcomes. It is a medical term used to describe the process of determining the relevance, effectiveness, and efficiency of a program in achieving its goals and objectives. Program evaluation involves collecting and analyzing data related to various aspects of the program, such as its reach, impact, cost-effectiveness, and quality. The results of program evaluation can be used to improve the design and implementation of existing programs or to inform the development of new ones. It is a critical tool for ensuring that healthcare programs are meeting the needs of their intended audiences and delivering high-quality care in an efficient and effective manner.

"Forecasting" is not a term that has a specific medical definition. It is a general term used in various fields, including finance, economics, and meteorology, to describe the process of making predictions or estimates about future events or trends based on historical data, trends, and other relevant factors. In healthcare and public health, forecasting may be used to predict the spread of diseases, identify potential shortages of resources such as hospital beds or medical equipment, or plan for future health care needs. However, there is no medical definition for "forecasting" itself.

In the context of medical education, a curriculum refers to the planned and organized sequence of experiences and learning opportunities designed to achieve specific educational goals and objectives. It outlines the knowledge, skills, and attitudes that medical students or trainees are expected to acquire during their training program. The curriculum may include various components such as lectures, small group discussions, clinical rotations, simulations, and other experiential learning activities. It is typically developed and implemented by medical education experts and faculty members in consultation with stakeholders, including learners, practitioners, and patients.

Health Insurance is a type of insurance that covers the whole or a part of the risk of a person incurring medical expenses, spreading the risk over a large number of persons. By purchasing health insurance, insured individuals pay a premium to an insurance company, which then pools those funds with other policyholders' premiums to pay for the medical care costs of individuals who become ill or injured. The coverage can include hospitalization, medical procedures, prescription drugs, and preventive care, among other services. The goal of health insurance is to provide financial protection against unexpected medical expenses and to make healthcare services more affordable.

Data collection in the medical context refers to the systematic gathering of information relevant to a specific research question or clinical situation. This process involves identifying and recording data elements, such as demographic characteristics, medical history, physical examination findings, laboratory results, and imaging studies, from various sources including patient interviews, medical records, and diagnostic tests. The data collected is used to support clinical decision-making, inform research hypotheses, and evaluate the effectiveness of treatments or interventions. It is essential that data collection is performed in a standardized and unbiased manner to ensure the validity and reliability of the results.

Health services needs refer to the population's requirement for healthcare services based on their health status, disease prevalence, and clinical guidelines. These needs can be categorized into normative needs (based on expert opinions or clinical guidelines) and expressed needs (based on individuals' perceptions of their own healthcare needs).

On the other hand, health services demand refers to the quantity of healthcare services that consumers are willing and able to pay for, given their preferences, values, and financial resources. Demand is influenced by various factors such as price, income, education level, and cultural beliefs.

It's important to note that while needs represent a population's requirement for healthcare services, demand reflects the actual utilization of these services. Understanding both health services needs and demand is crucial in planning and delivering effective healthcare services that meet the population's requirements while ensuring efficient resource allocation.

Quality of Life (QOL) is a broad, multidimensional concept that usually includes an individual's physical health, psychological state, level of independence, social relationships, personal beliefs, and their relationship to salient features of their environment. It reflects the impact of disease and treatment on a patient's overall well-being and ability to function in daily life.

The World Health Organization (WHO) defines QOL as "an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns." It is a subjective concept, meaning it can vary greatly from person to person.

In healthcare, QOL is often used as an outcome measure in clinical trials and other research studies to assess the impact of interventions or treatments on overall patient well-being.

I'm sorry for any confusion, but "poverty" is not a medical condition or term. It is a social condition defined by the World Bank as "pronounced deprivation in well-being," and measured through indicators such as income, consumption, and access to basic services. Poverty can have significant impacts on health outcomes and healthcare access, but it is not considered a medical diagnosis. If you have any questions related to health or medicine, I'd be happy to try my best to help answer them!

Socioeconomic factors are a range of interconnected conditions and influences that affect the opportunities and resources a person or group has to maintain and improve their health and well-being. These factors include:

1. Economic stability: This includes employment status, job security, income level, and poverty status. Lower income and lack of employment are associated with poorer health outcomes.
2. Education: Higher levels of education are generally associated with better health outcomes. Education can affect a person's ability to access and understand health information, as well as their ability to navigate the healthcare system.
3. Social and community context: This includes factors such as social support networks, discrimination, and community safety. Strong social supports and positive community connections are associated with better health outcomes, while discrimination and lack of safety can negatively impact health.
4. Healthcare access and quality: Access to affordable, high-quality healthcare is an important socioeconomic factor that can significantly impact a person's health. Factors such as insurance status, availability of providers, and cultural competency of healthcare systems can all affect healthcare access and quality.
5. Neighborhood and built environment: The physical conditions in which people live, work, and play can also impact their health. Factors such as housing quality, transportation options, availability of healthy foods, and exposure to environmental hazards can all influence health outcomes.

Socioeconomic factors are often interrelated and can have a cumulative effect on health outcomes. For example, someone who lives in a low-income neighborhood with limited access to healthy foods and safe parks may also face challenges related to employment, education, and healthcare access that further impact their health. Addressing socioeconomic factors is an important part of promoting health equity and reducing health disparities.

A diet, in medical terms, refers to the planned and regular consumption of food and drinks. It is a balanced selection of nutrient-rich foods that an individual eats on a daily or periodic basis to meet their energy needs and maintain good health. A well-balanced diet typically includes a variety of fruits, vegetables, whole grains, lean proteins, and low-fat dairy products.

A diet may also be prescribed for therapeutic purposes, such as in the management of certain medical conditions like diabetes, hypertension, or obesity. In these cases, a healthcare professional may recommend specific restrictions or modifications to an individual's regular diet to help manage their condition and improve their overall health.

It is important to note that a healthy and balanced diet should be tailored to an individual's age, gender, body size, activity level, and any underlying medical conditions. Consulting with a healthcare professional, such as a registered dietitian or nutritionist, can help ensure that an individual's dietary needs are being met in a safe and effective way.

I'm sorry for any confusion, but "income" is not a medical term. Income is an economic term that refers to the inflow of monetary resources or earnings that an individual or household receives from various sources, such as employment, investments, or government benefits. It is typically used in financial and economic contexts rather than medical ones. If you have any questions related to medical terminology or concepts, I would be happy to help with those!

Population dynamics, in the context of public health and epidemiology, refers to the study of the changes in size and structure of a population over time, as well as the factors that contribute to those changes. This can include birth rates, death rates, migration patterns, aging, and other demographic characteristics. Understanding population dynamics is crucial for planning and implementing public health interventions, such as vaccination programs or disease prevention strategies, as they allow researchers and policymakers to identify vulnerable populations, predict future health trends, and evaluate the impact of public health initiatives.

Medicare is a social insurance program in the United States, administered by the Centers for Medicare & Medicaid Services (CMS), that provides health insurance coverage to people who are aged 65 and over; or who have certain disabilities; or who have End-Stage Renal Disease (permanent kidney failure requiring dialysis or a transplant).

The program consists of four parts:

1. Hospital Insurance (Part A), which helps pay for inpatient care in hospitals, skilled nursing facilities, hospices, and home health care.
2. Medical Insurance (Part B), which helps pay for doctors' services, outpatient care, medical supplies, and preventive services.
3. Medicare Advantage Plans (Part C), which are private insurance plans that provide all of your Part A and Part B benefits, and may include additional benefits like dental, vision, and hearing coverage.
4. Prescription Drug Coverage (Part D), which helps pay for medications doctors prescribe for treatment.

Medicare is funded by payroll taxes, premiums paid by beneficiaries, and general revenue. Beneficiaries typically pay a monthly premium for Part B and Part D coverage, while Part A is generally free for those who have worked and paid Medicare taxes for at least 40 quarters.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

A research design in medical or healthcare research is a systematic plan that guides the execution and reporting of research to address a specific research question or objective. It outlines the overall strategy for collecting, analyzing, and interpreting data to draw valid conclusions. The design includes details about the type of study (e.g., experimental, observational), sampling methods, data collection techniques, data analysis approaches, and any potential sources of bias or confounding that need to be controlled for. A well-defined research design helps ensure that the results are reliable, generalizable, and relevant to the research question, ultimately contributing to evidence-based practice in medicine and healthcare.

Medical education, undergraduate, refers to the initial formal educational phase in which students learn the basic sciences and clinical skills required to become a physician. In the United States, this typically involves completing a four-year Bachelor's degree followed by four years of medical school. The first two years of medical school are primarily focused on classroom instruction in subjects such as anatomy, physiology, biochemistry, pharmacology, and pathology. The final two years involve clinical rotations, during which students work directly with patients under the supervision of licensed physicians. After completing medical school, graduates must then complete a residency program in their chosen specialty before they are eligible to practice medicine independently.

Biomedical research is a branch of scientific research that involves the study of biological processes and diseases in order to develop new treatments and therapies. This type of research often involves the use of laboratory techniques, such as cell culture and genetic engineering, as well as clinical trials in humans. The goal of biomedical research is to advance our understanding of how living organisms function and to find ways to prevent and treat various medical conditions. It encompasses a wide range of disciplines, including molecular biology, genetics, immunology, pharmacology, and neuroscience, among others. Ultimately, the aim of biomedical research is to improve human health and well-being.

Clinical protocols, also known as clinical practice guidelines or care paths, are systematically developed statements that assist healthcare professionals and patients in making decisions about the appropriate healthcare for specific clinical circumstances. They are based on a thorough evaluation of the available scientific evidence and consist of a set of recommendations that are designed to optimize patient outcomes, improve the quality of care, and reduce unnecessary variations in practice. Clinical protocols may cover a wide range of topics, including diagnosis, treatment, follow-up, and disease prevention, and are developed by professional organizations, government agencies, and other groups with expertise in the relevant field.

I believe there may be a slight misunderstanding in your question. "Plant leaves" are not a medical term, but rather a general biological term referring to a specific organ found in plants.

Leaves are organs that are typically flat and broad, and they are the primary site of photosynthesis in most plants. They are usually green due to the presence of chlorophyll, which is essential for capturing sunlight and converting it into chemical energy through photosynthesis.

While leaves do not have a direct medical definition, understanding their structure and function can be important in various medical fields, such as pharmacognosy (the study of medicinal plants) or environmental health. For example, certain plant leaves may contain bioactive compounds that have therapeutic potential, while others may produce allergens or toxins that can impact human health.

Biological evolution is the change in the genetic composition of populations of organisms over time, from one generation to the next. It is a process that results in descendants differing genetically from their ancestors. Biological evolution can be driven by several mechanisms, including natural selection, genetic drift, gene flow, and mutation. These processes can lead to changes in the frequency of alleles (variants of a gene) within populations, resulting in the development of new species and the extinction of others over long periods of time. Biological evolution provides a unifying explanation for the diversity of life on Earth and is supported by extensive evidence from many different fields of science, including genetics, paleontology, comparative anatomy, and biogeography.

Feeding behavior refers to the various actions and mechanisms involved in the intake of food and nutrition for the purpose of sustaining life, growth, and health. This complex process encompasses a coordinated series of activities, including:

1. Food selection: The identification, pursuit, and acquisition of appropriate food sources based on sensory cues (smell, taste, appearance) and individual preferences.
2. Preparation: The manipulation and processing of food to make it suitable for consumption, such as chewing, grinding, or chopping.
3. Ingestion: The act of transferring food from the oral cavity into the digestive system through swallowing.
4. Digestion: The mechanical and chemical breakdown of food within the gastrointestinal tract to facilitate nutrient absorption and eliminate waste products.
5. Assimilation: The uptake and utilization of absorbed nutrients by cells and tissues for energy production, growth, repair, and maintenance.
6. Elimination: The removal of undigested material and waste products from the body through defecation.

Feeding behavior is regulated by a complex interplay between neural, hormonal, and psychological factors that help maintain energy balance and ensure adequate nutrient intake. Disruptions in feeding behavior can lead to various medical conditions, such as malnutrition, obesity, eating disorders, and gastrointestinal motility disorders.

A computer simulation is a process that involves creating a model of a real-world system or phenomenon on a computer and then using that model to run experiments and make predictions about how the system will behave under different conditions. In the medical field, computer simulations are used for a variety of purposes, including:

1. Training and education: Computer simulations can be used to create realistic virtual environments where medical students and professionals can practice their skills and learn new procedures without risk to actual patients. For example, surgeons may use simulation software to practice complex surgical techniques before performing them on real patients.
2. Research and development: Computer simulations can help medical researchers study the behavior of biological systems at a level of detail that would be difficult or impossible to achieve through experimental methods alone. By creating detailed models of cells, tissues, organs, or even entire organisms, researchers can use simulation software to explore how these systems function and how they respond to different stimuli.
3. Drug discovery and development: Computer simulations are an essential tool in modern drug discovery and development. By modeling the behavior of drugs at a molecular level, researchers can predict how they will interact with their targets in the body and identify potential side effects or toxicities. This information can help guide the design of new drugs and reduce the need for expensive and time-consuming clinical trials.
4. Personalized medicine: Computer simulations can be used to create personalized models of individual patients based on their unique genetic, physiological, and environmental characteristics. These models can then be used to predict how a patient will respond to different treatments and identify the most effective therapy for their specific condition.

Overall, computer simulations are a powerful tool in modern medicine, enabling researchers and clinicians to study complex systems and make predictions about how they will behave under a wide range of conditions. By providing insights into the behavior of biological systems at a level of detail that would be difficult or impossible to achieve through experimental methods alone, computer simulations are helping to advance our understanding of human health and disease.

Substance-related disorders, as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), refer to a group of conditions caused by the use of substances such as alcohol, drugs, or medicines. These disorders are characterized by a problematic pattern of using a substance that leads to clinically significant impairment or distress. They can be divided into two main categories: substance use disorders and substance-induced disorders. Substance use disorders involve a pattern of compulsive use despite negative consequences, while substance-induced disorders include conditions such as intoxication, withdrawal, and substance/medication-induced mental disorders. The specific diagnosis depends on the type of substance involved, the patterns of use, and the presence or absence of physiological dependence.

I apologize for any confusion, but "Australia" is not a medical term or concept. It is the world's largest island and smallest continent, located in the Southern Hemisphere, surrounded by the Pacific and Indian Oceans. It is composed of many diverse ecosystems, including deserts, rainforests, and coastal areas, and is home to a wide variety of unique plant and animal species.

If you have any questions related to medical terminology or health-related topics, I would be happy to try and help answer them for you!

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Quality of health care is a term that refers to the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge. It encompasses various aspects such as:

1. Clinical effectiveness: The use of best available evidence to make decisions about prevention, diagnosis, treatment, and care. This includes considering the benefits and harms of different options and making sure that the most effective interventions are used.
2. Safety: Preventing harm to patients and minimizing risks associated with healthcare. This involves identifying potential hazards, implementing measures to reduce errors, and learning from adverse events to improve systems and processes.
3. Patient-centeredness: Providing care that is respectful of and responsive to individual patient preferences, needs, and values. This includes ensuring that patients are fully informed about their condition and treatment options, involving them in decision-making, and providing emotional support throughout the care process.
4. Timeliness: Ensuring that healthcare services are delivered promptly and efficiently, without unnecessary delays. This includes coordinating care across different providers and settings to ensure continuity and avoid gaps in service.
5. Efficiency: Using resources wisely and avoiding waste, while still providing high-quality care. This involves considering the costs and benefits of different interventions, as well as ensuring that healthcare services are equitably distributed.
6. Equitability: Ensuring that all individuals have access to quality healthcare services, regardless of their socioeconomic status, race, ethnicity, gender, age, or other factors. This includes addressing disparities in health outcomes and promoting fairness and justice in healthcare.

Overall, the quality of health care is a multidimensional concept that requires ongoing evaluation and improvement to ensure that patients receive the best possible care.

Cognition refers to the mental processes involved in acquiring, processing, and utilizing information. These processes include perception, attention, memory, language, problem-solving, and decision-making. Cognitive functions allow us to interact with our environment, understand and respond to stimuli, learn new skills, and remember experiences.

In a medical context, cognitive function is often assessed as part of a neurological or psychiatric evaluation. Impairments in cognition can be caused by various factors, such as brain injury, neurodegenerative diseases (e.g., Alzheimer's disease), infections, toxins, and mental health conditions. Assessing cognitive function helps healthcare professionals diagnose conditions, monitor disease progression, and develop treatment plans.

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

An "ecosystem" is not a term that has a specific medical definition, as it is a concept that is more commonly used in the fields of ecology and environmental science. However, I can provide you with the general ecological definition of an ecosystem:

An ecosystem is a community of living organisms interacting with each other and their non-living environment, including both biotic factors (plants, animals, microorganisms) and abiotic factors (climate, soil, water, and air). These interactions create a complex network of relationships that form the foundation of ecological processes, such as energy flow, nutrient cycling, and population dynamics.

While there is no direct medical definition for an ecosystem, understanding the principles of ecosystems can have important implications for human health. For example, healthy ecosystems can provide clean air and water, regulate climate, support food production, and offer opportunities for recreation and relaxation, all of which contribute to overall well-being. Conversely, degraded ecosystems can lead to increased exposure to environmental hazards, reduced access to natural resources, and heightened risks of infectious diseases. Therefore, maintaining the health and integrity of ecosystems is crucial for promoting human health and preventing disease.

I am not aware of a specific medical definition for the term "China." Generally, it is used to refer to:

1. The People's Republic of China (PRC), which is a country in East Asia. It is the most populous country in the world and the fourth largest by geographical area. Its capital city is Beijing.
2. In a historical context, "China" was used to refer to various dynasties and empires that existed in East Asia over thousands of years. The term "Middle Kingdom" or "Zhongguo" (中国) has been used by the Chinese people to refer to their country for centuries.
3. In a more general sense, "China" can also be used to describe products or goods that originate from or are associated with the People's Republic of China.

If you have a specific context in which you encountered the term "China" related to medicine, please provide it so I can give a more accurate response.

Statistical data interpretation involves analyzing and interpreting numerical data in order to identify trends, patterns, and relationships. This process often involves the use of statistical methods and tools to organize, summarize, and draw conclusions from the data. The goal is to extract meaningful insights that can inform decision-making, hypothesis testing, or further research.

In medical contexts, statistical data interpretation is used to analyze and make sense of large sets of clinical data, such as patient outcomes, treatment effectiveness, or disease prevalence. This information can help healthcare professionals and researchers better understand the relationships between various factors that impact health outcomes, develop more effective treatments, and identify areas for further study.

Some common statistical methods used in data interpretation include descriptive statistics (e.g., mean, median, mode), inferential statistics (e.g., hypothesis testing, confidence intervals), and regression analysis (e.g., linear, logistic). These methods can help medical professionals identify patterns and trends in the data, assess the significance of their findings, and make evidence-based recommendations for patient care or public health policy.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

A randomized controlled trial (RCT) is a type of clinical study in which participants are randomly assigned to receive either the experimental intervention or the control condition, which may be a standard of care, placebo, or no treatment. The goal of an RCT is to minimize bias and ensure that the results are due to the intervention being tested rather than other factors. This design allows for a comparison between the two groups to determine if there is a significant difference in outcomes. RCTs are often considered the gold standard for evaluating the safety and efficacy of medical interventions, as they provide a high level of evidence for causal relationships between the intervention and health outcomes.

I'm sorry for any confusion, but "Linear Models" is actually a term from the field of statistics and machine learning, rather than medicine. A linear model is a type of statistical model that is used to analyze the relationship between two or more variables. In a linear model, the relationship between the dependent variable (the outcome or result) and the independent variable(s) (the factors being studied) is assumed to be linear, meaning that it can be described by a straight line on a graph.

The equation for a simple linear model with one independent variable (x) and one dependent variable (y) looks like this:

y = β0 + β1*x + ε

In this equation, β0 is the y-intercept or the value of y when x equals zero, β1 is the slope or the change in y for each unit increase in x, and ε is the error term or the difference between the actual values of y and the predicted values of y based on the linear model.

Linear models are widely used in medical research to study the relationship between various factors (such as exposure to a risk factor or treatment) and health outcomes (such as disease incidence or mortality). They can also be used to adjust for confounding variables, which are factors that may influence both the independent variable and the dependent variable, and thus affect the observed relationship between them.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

Clinical trials are research studies that involve human participants and are designed to evaluate the safety and efficacy of new medical treatments, drugs, devices, or behavioral interventions. The purpose of clinical trials is to determine whether a new intervention is safe, effective, and beneficial for patients, as well as to compare it with currently available treatments. Clinical trials follow a series of phases, each with specific goals and criteria, before a new intervention can be approved by regulatory authorities for widespread use.

Clinical trials are conducted according to a protocol, which is a detailed plan that outlines the study's objectives, design, methodology, statistical analysis, and ethical considerations. The protocol is developed and reviewed by a team of medical experts, statisticians, and ethicists, and it must be approved by an institutional review board (IRB) before the trial can begin.

Participation in clinical trials is voluntary, and participants must provide informed consent before enrolling in the study. Informed consent involves providing potential participants with detailed information about the study's purpose, procedures, risks, benefits, and alternatives, as well as their rights as research subjects. Participants can withdraw from the study at any time without penalty or loss of benefits to which they are entitled.

Clinical trials are essential for advancing medical knowledge and improving patient care. They help researchers identify new treatments, diagnostic tools, and prevention strategies that can benefit patients and improve public health. However, clinical trials also pose potential risks to participants, including adverse effects from experimental interventions, time commitment, and inconvenience. Therefore, it is important for researchers to carefully design and conduct clinical trials to minimize risks and ensure that the benefits outweigh the risks.

"Length of Stay" (LOS) is a term commonly used in healthcare to refer to the amount of time a patient spends receiving care in a hospital, clinic, or other healthcare facility. It is typically measured in hours, days, or weeks and can be used as a metric for various purposes such as resource planning, quality assessment, and reimbursement. The length of stay can vary depending on the type of illness or injury, the severity of the condition, the patient's response to treatment, and other factors. It is an important consideration in healthcare management and can have significant implications for both patients and providers.

An algorithm is not a medical term, but rather a concept from computer science and mathematics. In the context of medicine, algorithms are often used to describe step-by-step procedures for diagnosing or managing medical conditions. These procedures typically involve a series of rules or decision points that help healthcare professionals make informed decisions about patient care.

For example, an algorithm for diagnosing a particular type of heart disease might involve taking a patient's medical history, performing a physical exam, ordering certain diagnostic tests, and interpreting the results in a specific way. By following this algorithm, healthcare professionals can ensure that they are using a consistent and evidence-based approach to making a diagnosis.

Algorithms can also be used to guide treatment decisions. For instance, an algorithm for managing diabetes might involve setting target blood sugar levels, recommending certain medications or lifestyle changes based on the patient's individual needs, and monitoring the patient's response to treatment over time.

Overall, algorithms are valuable tools in medicine because they help standardize clinical decision-making and ensure that patients receive high-quality care based on the latest scientific evidence.

Health status is a term used to describe the overall condition of an individual's health, including physical, mental, and social well-being. It is often assessed through various measures such as medical history, physical examination, laboratory tests, and self-reported health assessments. Health status can be used to identify health disparities, track changes in population health over time, and evaluate the effectiveness of healthcare interventions.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Statistical models are mathematical representations that describe the relationship between variables in a given dataset. They are used to analyze and interpret data in order to make predictions or test hypotheses about a population. In the context of medicine, statistical models can be used for various purposes such as:

1. Disease risk prediction: By analyzing demographic, clinical, and genetic data using statistical models, researchers can identify factors that contribute to an individual's risk of developing certain diseases. This information can then be used to develop personalized prevention strategies or early detection methods.

2. Clinical trial design and analysis: Statistical models are essential tools for designing and analyzing clinical trials. They help determine sample size, allocate participants to treatment groups, and assess the effectiveness and safety of interventions.

3. Epidemiological studies: Researchers use statistical models to investigate the distribution and determinants of health-related events in populations. This includes studying patterns of disease transmission, evaluating public health interventions, and estimating the burden of diseases.

4. Health services research: Statistical models are employed to analyze healthcare utilization, costs, and outcomes. This helps inform decisions about resource allocation, policy development, and quality improvement initiatives.

5. Biostatistics and bioinformatics: In these fields, statistical models are used to analyze large-scale molecular data (e.g., genomics, proteomics) to understand biological processes and identify potential therapeutic targets.

In summary, statistical models in medicine provide a framework for understanding complex relationships between variables and making informed decisions based on data-driven insights.

Health services accessibility refers to the degree to which individuals and populations are able to obtain needed health services in a timely manner. It includes factors such as physical access (e.g., distance, transportation), affordability (e.g., cost of services, insurance coverage), availability (e.g., supply of providers, hours of operation), and acceptability (e.g., cultural competence, language concordance).

According to the World Health Organization (WHO), accessibility is one of the key components of health system performance, along with responsiveness and fair financing. Improving accessibility to health services is essential for achieving universal health coverage and ensuring that everyone has access to quality healthcare without facing financial hardship. Factors that affect health services accessibility can vary widely between and within countries, and addressing these disparities requires a multifaceted approach that includes policy interventions, infrastructure development, and community engagement.

Smoking is not a medical condition, but it's a significant health risk behavior. Here is the definition from a public health perspective:

Smoking is the act of inhaling and exhaling the smoke of burning tobacco that is commonly consumed through cigarettes, pipes, and cigars. The smoke contains over 7,000 chemicals, including nicotine, tar, carbon monoxide, and numerous toxic and carcinogenic substances. These toxins contribute to a wide range of diseases and health conditions, such as lung cancer, heart disease, stroke, chronic obstructive pulmonary disease (COPD), and various other cancers, as well as adverse reproductive outcomes and negative impacts on the developing fetus during pregnancy. Smoking is highly addictive due to the nicotine content, which makes quitting smoking a significant challenge for many individuals.

Primary health care is defined by the World Health Organization (WHO) as:

"Essential health care that is based on practical, scientifically sound and socially acceptable methods and technology made universally accessible to individuals and families in the community through their full participation and at a cost that the community and country can afford. It forms an integral part both of the country's health system, of which it is the central function and main focus, and of the overall social and economic development of the community. It is the first level of contact of individuals, the family and community with the national health system bringing health care as close as possible to where people live and work, and constitutes the first element of a continuing health care process."

Primary health care includes a range of services such as preventive care, health promotion, curative care, rehabilitation, and palliative care. It is typically provided by a team of health professionals including doctors, nurses, midwives, pharmacists, and other community health workers. The goal of primary health care is to provide comprehensive, continuous, and coordinated care to individuals and families in a way that is accessible, affordable, and culturally sensitive.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

"Kristopher J. Hult: Research". University of Chicago - Department of Economics. Archived from the original on 2015-04-16. ... While a pharmaceutical company may view a product that fills a niche as innovative if it can produce a profit. A decline in ... Pharmaceutical innovations are currently guided by a patent system, the patent system protects the innovator of medicines for a ... Pharmaceutical innovation may not apply the same definition of "initiative" as other industries because while a product might ...
... management and economics of pharmacy; pharmaceutical technology; pharmaceutical chemistry and pharmacognosy. according to ... "Perm State Pharmaceutical Academy") is a higher educational institution in Perm that trains specialists with a pharmaceutical ... the Perm State Pharmaceutical Institute received the status of an academy and was renamed the Perm State Pharmaceutical Academy ... pharmaceutical technology; pharmaceutical chemistry and pharmacognosy. "История". Сайт Пермской государственной ...
This is where the discipline of pharmaco-economics is often applied. This is a specialized field of health economics that looks ... Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a ... Pharmaceutical policy may also be used to respond to health crises. For example, Argentina launched REMEDIAR during its ... Pharmaceutical policy may also attempt to shape and inform prescribing. Prescribing may be limited to physicians or include ...
Faculty of Economics (Management; Finance, banking and insurance; Economics; Business, trade and exchange activities; Public ... Pharmaceutical Faculty (Pharmacy); Stomatological Faculty (Dentistry). Department of Slavonic Philology and General Linguistics ... Department of Economics, Management, Business; Department of Computer Science; Department of International Relations and ...
Economics and Management ; Biological and Biotechnology Sciences ; Medical and Pharmaceutical Sciences ; Engineering Sciences ... Dental and pharmaceutical studies (six to ten years) ; Medical studies (six to eleven). The University of Monastir adapted the ... Faculty of Economics and Management of Mahdia ; National Engineering School of Monastir; Graduate School of Health Sciences and ... The University of Monastir is an active institution in the fields of pharmaceutical studies and dental surgery, as well as ...
"NHS pays twice the price for generic medicines that manufacturers charge, finds report". Pharmaceutical Journal. 26 June 2019. ... This is based on a new analysis conducted by the Office of Health Economics. British Generic Manufacturers Association " ... Articles with short description, Short description is different from Wikidata, Pharmaceutical industry trade groups, ... Pharmaceutical industry in the United Kingdom, Trade associations based in the United Kingdom). ...
Pharmaceutical Economics and Public Policy. CRC Press, 2007. ISBN 9781439801345. P. 208 Biasotti, Tony (9 April 2022). "In ... KAI Pharmaceuticals (Acq 2012) deCODE genetics (Acq 2012) Onyx Pharmaceuticals (Acq 2013) NextCODE genetics (Spun off 2013) ... Pharmaceutical companies established in 1980, Biotechnology companies established in 1980, Pharmaceutical companies of the ... Kim, Rachel (2019). Economics and management in the biopharmaceutical industry in the USA : evolution and strategic change. ...
CPIA is a member and also a standing council director's unit of China Federation of Industrial Economics. Besides, CPIA is a ... Its members are mainly from large and medium-sized pharmaceutical corporations, pharmaceutical machinery and medicinal glass ... The China Pharmaceutical Industry Association (CPIA) was founded in September 1988 and it is a non-governmental, non-profit ... Gu Jiaqi, the Senior Vice Chairman of China Federation of Industrial Economics; Specially Invited Advisor, Mr. Yu Mingde, the ...
Office of health Economics. "International Comparison of Medicines Usage: Quantitative Analysis" (PDF). Association of the ... British Pharmaceutical Industry. Archived from the original (PDF) on 11 November 2015. Retrieved 2 July 2015. "Classi di ...
Office of health Economics. "International Comparison of Medicines Usage: Quantitative Analysis" (PDF). Association of the ... and the democratization of budgetary arbitration to counter pressure from the pharmaceutical industry. The entire population ... British Pharmaceutical Industry. Archived from the original (PDF) on 11 October 2017. Retrieved 2 July 2015. Paul V. Dutton. " ... Retrieved from http://www.eui.eu/Research/Library/ResearchGuides/Economics/Statistics/DataPortal/EU-SILC.aspx Chevreul K, Berg ...
The economics of innovation literature suggests that patent thickets may have an ambiguous effect on patent transactions. On ... It has been suggested by some that this is particularly true in fields such as software or pharmaceuticals, but Sir Robin Jacob ... RAND Journal of Economics, 41(3), 472-503. "Improving efficiency in the 'market for innovation'". 29 November 2008. In re ... Frontiers of Economics and Globalization. Vol. 2. Emerald Group. pp. 233-261. ISBN 978-0-444-52764-6. European Commission (28 ...
Office of health Economics. "International Comparison of Medicines Usage: Quantitative Analysis" (PDF). Association of the ... While Spain's universal health care covers a substantial amount including many basic primary and pharmaceutical services, it ... The European Journal of Health Economics. 11 (5): 487-498. doi:10.1007/s10198-009-0204-z. ISSN 1618-7598. JSTOR 40963270. PMID ... The European Journal of Health Economics. 13 (6): 741-754. doi:10.1007/s10198-011-0327-x. ISSN 1618-7598. JSTOR 23275619. PMC ...
The Pharmaceutical Management Agency of New Zealand (PHARMAC) was set up in 1993 to decide which medications the government ... Office of health Economics. "International Comparison of Medicines Usage: Quantitative Analysis" (PDF). Association of the ... "Viagra from the pharmacist: insight from reclassification in New Zealand". Pharmaceutical Journal. 31 January 2018. Retrieved 2 ... New Zealand Ministry of Health World Health Organization Statistical Information System (WHOSIS) Pharmaceutical Management ...
Innovation in Pharmaceutical Markets". Forum for Health Economics & Policy. 12 (1): 5. doi:10.2202/1558-9544.1138. PMC 5659838 ... While pharmaceutical companies have justified the development of me-toos as offering incremental improvements in efficacy, side ... The first-in-class β-blocker pronethalol was developed by James Black at ICI Pharmaceuticals. It was followed by propranolol, ... Additionally, pharmaceutical companies depend on incremental innovations to provide the revenue that will support the ...
Office of health Economics. "International Comparison of Medicines Usage: Quantitative Analysis" (PDF). Association of the ... British Pharmaceutical Industry. Archived from the original (PDF) on 11 November 2015. Retrieved 2 July 2015. "Outcomes in EHCI ... Health Economics. 14 (Suppl 1): S7-S23. doi:10.1002/hec.1026. PMID 16161199. Austria. European Observatory on Health Care ...
The Pharmaceutical Benefits Scheme (PBS) subsidises certain prescribed pharmaceuticals. The PBS pre-dates Medicare, being ... OCLC 960840881.{{cite book}}: CS1 maint: location missing publisher (link) Office of health Economics. "International ... "Pharmaceutical Benefits Scheme (PBS) , About the PBS". www.pbs.gov.au. Retrieved 27 May 2017. "Report of the National Advisory ... Under the Pharmaceutical Benefits Scheme, some prescription medications are subsidised by the Australian Government. The PBS ...
The Faculty of Economics and Business Administration has also been awarded with an international Association to Advance ... and Pharmaceutical Sciences. In the 1960s, there were several student demonstrations at Ghent University, notably around the ... It was followed by Economics and Veterinary Medicine in 1968, Psychology and Pedagogy, as well as Bioengineering, in 1969, ... ". "Faculty of Economics and Business Administration". Archived from the original on 3 April 2013. Retrieved 6 April 2013. " ...
If the patient's pharmaceutical expenses have exceeded the annual limit, the patient receives the medication free of charge at ... Office of health Economics. "International Comparison of Medicines Usage: Quantitative Analysis" (PDF). Association of the ... British Pharmaceutical Industry. Archived from the original (PDF) on 11 October 2017. Retrieved 2 July 2015. "The Swedish ...
Decisions on PBS listing are generally made on a health economics perspective, using cost-effectiveness analysis. Cost- ... The Pharmaceutical Benefits Scheme - an Overview Goddard, M (2014). "How the Pharmaceutical Benefits Scheme began" (PDF). Med J ... Reference pricing for pharmaceuticals: is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical ... The Act provided for free pharmaceuticals, with benefits restricted to medicines listed in the Commonwealth Pharmaceutical ...
Swiss Pharmaceutical Society (2000). Swiss Pharmaceutical Society (ed.). Index Nominum 2000: International Drug Directory. ... 134-. ISBN 978-3-88763-075-1. Baker CE (1974). Physicians' Desk Reference (28 ed.). Oradell, NJ 07649: Medical Economics ...
Professor Diane Coyle OBE For services to economics and the public understanding of economics. Patrick Lorne Crerar. For ... For services to pharmacy and pharmaceutical sciences. Thomas Auguste Read Delay, Chief Executive, the Carbon Trust. For ... London School of Economics and Political Science. For services to Economics and Public Policy. Graham Stuart Brady, MP, Member ... For services to economics and public policy. Professor Norman David Black. For services to higher education, science and the ...
... is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical ... 9. "Unichem Labs gets EIR from USFDA for Goa facility" Economics times.com. Published on 30 June 2017. 10. "Unichem Lab ... Pharmaceutical companies of India, Pharmaceutical companies established in 1944, Indian companies established in 1944, Indian ... "Contact Pharmaceutical Company India - Unichem Laboratories". Unichemlabs.com. Retrieved 3 October 2010. "Pharmaceutical ...
... of Education Faculty of Law Faculty of Economics Faculty of Science Medical School Dental School Faculty of Pharmaceutical ... Achieved a pharmaceutical qualification. Including the number of legal studies (professional degree courses) As of May 1, 2021 ... 1976: the Faculty of Pharmaceutical Sciences was established. 1979: the Dental School was established (in Shikata Campus). 1980 ... economics and literature at the same time as the university was founded. In those days, this was the only faculty of law in the ...
Maskus, K., Institute for International Economics, Washington DC. Facilitating Humanitarian Access to Pharmaceutical and ...
Physicians Desk Reference to Pharmaceutical Specialties and Biologicals. Medical Economics. 1968. p. 624. Federal Register. ... It was developed by Ciba Pharmaceutical Company. A study found that, measured by 17-ketosteroid excretion, 300 mg testosterone ...
Drug design Drug repositioning Pharmaceutical engineering Pharmaceutical manufacturing Generic drug International Conference on ... Journal of Health Economics. 47: 20-33. doi:10.1016/j.jhealeco.2016.01.012. hdl:10161/12742. PMID 26928437. Taylor D (2015). " ... List of pharmaceutical companies Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A, et al. (July 1, 2016). " ... Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified ...
A major factor in the economics of vaccines is intellectual property law. IP currently operates by granting pharmaceutical ... The economics of monopoly power give the monopolist a strong financial incentive to use value-based pricing and set prices that ... Pharmaceutical companies have few financial incentives to develop treatments for neglected tropical diseases in poor countries ... The United States is also the country with the highest profits for pharmaceutical companies, and the highest drug costs for ...
Anis, Aslam H.; Wen, Quan (1998-01-01). "Price regulation of pharmaceuticals in Canada". Journal of Health Economics. 17 (1): ... Anis completed his BSS (Honours) in economics at the University of Dhaka (1981) and his MA and PhD in economics at Carleton ... His earliest research in the pharmaceuticals showed that pricing regulations of drug plans were responsible for higher generic ... Anis's research spans several areas, including pharmaceutical pricing and regulation, pharmacoeconomic policy, economic ...
... approached a small family-owned manufacturer of active pharmaceutical ingredients in New Jersey, Jacobus Pharmaceuticals, about ... The European Journal of Health Economics. 15 (4): 335-340. doi:10.1007/s10198-014-0560-1. PMID 24435513. Lowe D (October 21, ... Jacobus Pharmaceutical had been manufacturing and giving it away for free since the 1990s. The FDA decision dropped the stock ... "Jacobus Pharmaceuticals". Drug R&D Insight. April 25, 2015. "BioMarin licenses North American rights to rare disease drug, ...
... pharmaceuticals and technical books. Once information is recorded "on paper, in a computer, or on a compact disc, it can be ... "The Contributions of the Economics of Information to Twentieth Century Economics," Quarterly Journal of Economics, 115(4), pp. ... Information economics or the economics of information is the branch of microeconomics that studies how information and ... Handbook of Experimental Economics Results, v. 1, Elsevier, Part 2: Market Economics of Uncertainty and Information and Part 4 ...
A sample of classes students in the Master of Science in Pharmaceutical Economics and Policy program will take, broken down by ... Pharmaceutical Economics and Policy (MS)*Curriculum. *. Pharmaceutical Economics and Policy (MS). *Admission Requirements* ... Regression Analysis in Pharmaceutical Economics and Policy. 3. PEP 870. Graduate Seminar in Pharmaceutical Economics and Policy ... Introduction to Health Economics and Outcomes Research. 3. PEP 870. Graduate Seminar in Pharmaceutical Economics and Policy 1. ...
Katonomics 6: the Economics of IP in Pharmaceuticals Jeremy Monday, December 12, 2011 - economics of pharmaceutical IP, Jeremy ... economics of pharmaceutical IP /. Jeremy Phillips /. Katonomics /. Nicola Searle / Katonomics 6: the Economics of IP in ... Economics of IP in Pharmaceuticals. No IP topic presses quite so many buttons for economists (and IPKat readers) as ... Katonomics 6: the Economics of IP in Pharmaceuticals Reviewed by Jeremy on Monday, December 12, 2011 Rating: 5 ...
... speakers examined the law and economics of recent competition interventions in pharmaceutical markets. ...
... 药物经济学 Online Apply Qualification Awarded. Masters Degree. ... 1International Economics and Trade (国际经济与贸易) ... Welcome to China Pharmaceutical University ( 中国药科大学 ) China ... Welcome to study at China Pharmaceutical University(中国
Central index of economics institutions (academic, governmental and non-profit) organized by country and US state. ... Economics Departments, Institutes and Research Centers in the World. Department of Pharmaceutical Economics and Policy. ... IDEAS: Economics research. All the economics literature on one site. NEP: New Economics papers. Subscribe to new additions to ... Economics Rankings. Various rankings of research in Economics & related fields. RePEc Genealogy. Who was a student of whom, ...
The Development Of Palestinian Pharmaceutical Industry Economics Essay. There are more than 4,000 Palestinian, Israeli, and ... HomeArticlesThe Development Of Palestinian Pharmaceutical Industry Economics Essay ... Pharmaceutical industry make good net income in PPI for illustration, Jerusalem Pharmaceuticals net net income $ 1.6 million in ... The constitution of pharmaceutical industry require investings with really high sums, entire assets of Al-Quds pharmaceutical ...
The Effects of Pharmaceutical Price Regulation on Probability of Patenting in OECD Countries. By Dwayne Russell in 2021, ... Home » Year » 2021 » The Effects of Pharmaceutical Price Regulation on Probability of Patenting in OECD Countries ... The introduction of parallel trade mechanisms allowing for the free trade of pharmaceutical goods in the European Economic Area ... These findings demonstrate the complexity in attempting to create policy to regulate rising pharmaceutical prices, as doing so ...
We show how characterizing optimal patent policy for the pharmaceutical industry only requires information about generic ... Health Economics eJournal. Subscribe to this fee journal for more curated articles on this topic ... Izhak, Olena and Saxell, Tanja and Takalo, Tuomas, Optimal Patent Policy for Pharmaceutical Industry (May 20, 2020). VATT ... We show how characterizing optimal patent policy for the pharmaceutical industry only requires information about generic ...
THE ECONOMICS OF BIDIL. The great majority of clinical trials of drugs in the United States are now funded by the ... Perspectives on the pharmaceutical industry. Health Aff (Millwood). 2001;20:136-149. ... Bodenheimer T. Uneasy alliance--clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342:1539-1544. ... Advising our patients requires that we understand the science behind this new pharmaceutical development. It also requires that ...
Lee VJ, Kai HP, Chen MI, Chow A, Ma S, Kee TG, Economics of neuraminidase inhibitor stockpiling for pandemic influenza, ... 2006 Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee ... Descriptions of 4 pharmaceutical-based pandemic influenza mitigation strategies * Table 2. Base-case economic results per ... Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies1 On This Page ...
Learn more about Economics and Management BSc (Hons) Program including the program highlights, fees, scholarships, events and ... The Economics and Management course looks at different aspects of economics and management. Those who pursue a more management ... The Economics and Management course looks at different aspects of economics and management. Those who pursue a more management ... Economics and Management graduates can claim exemptions from the examinations of a number of professional bodies. At present ...
"Kristopher J. Hult: Research". University of Chicago - Department of Economics. Archived from the original on 2015-04-16. ... While a pharmaceutical company may view a product that fills a niche as innovative if it can produce a profit. A decline in ... Pharmaceutical innovations are currently guided by a patent system, the patent system protects the innovator of medicines for a ... Pharmaceutical innovation may not apply the same definition of "initiative" as other industries because while a product might ...
IBC Advanced EC Competition Law 2009, London, April 2009 ...
Discipline: Pharmacoeconomics/Pharmaceutical Economics (MS, PhD). Pharmacoeconomics/Pharmaceutical Economics (MS, PhD). *Phad ...
Find new Health economics, HEOR, HTA and market access jobs at Jazz Pharmaceuticals. ... The latest Health Economics Jobs at Jazz Pharmaceuticals. ... Health Economics Jobs at Jazz Pharmaceuticals. Find the latest ... health economics jobs at Jazz Pharmaceuticals. Health economics, HEOR, HTA, pricing and market access jobs at Jazz ... New career opportunities for health economists at Jazz Pharmaceuticals. New health economist jobs are added daily on ...
Pharmaceutical Economics Edited by William S. Comanor, Stuart O. Schweitzer. Pharmaceutical Economics begins with an ... The Dictionary of Health Economics, Third Edition Anthony J. Culyer. This third edition of Anthony Culyers authoritative The ... Intellectual Property, Pharmaceuticals and Public Health Edited by Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán , ... The Elgar Companion to Health Economics, Second Edition Edited by Andrew M. Jones. This comprehensive collection brings ...
Economics. Producer prices for final demand rose 0.7% in August.. US wholesale inventories rose 0.6% month-over-month to $722 ... Apellis Pharmaceuticals, Inc. APLS shares tumbled 49% to $28.53 after the company reported mixed top-line results from the ... IVERIC bio, Inc. ISEE shares shot up 56% to $13.53 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and ... Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge. ...
Sustainable Value Added of Top European Pharmaceutical Manufacturers Authors. * Juliana Straková Keywords: benchmarking, ... We present the contribution to sustainability by top five great players on the field of pharmaceutical market in Europe. ... Findings This paper found several key issues: there is a little research of environmental impact generated by pharmaceutical ... It means that successful pharmaceutical companies using six analysed environmental resources create more value than required by ...
Pharmacy policy, pharmaceutical prices, pharmaceutical purchases, pharmaceutical costs, external reference price Abstract. ... Economics and Sociology: Vol. 7 No. 2 (2023): Health Policy, Economics and Sociology ... Pharmaceutical Price Regulation Policy: Recommendations for Georgia Authors. * Tamar Azikuri School of Health Sciences, ... In LMICs, most pharmaceutical expenditure is covered by out-of-pocket payments. Many different options for drug pricing and ...
Results of search for su:{Economics, Pharmaceutical.} Refine your search. *. Availability. * Limit to currently available ... Biotechnology and the economics of discovery in the pharmaceutical industry / Helen Simpson. by Simpson, Helen. ... Centre for Health Economics.. Series: Discussion paper (University of York). Centre for Health Economics ; ; 155Material type: ... Text; Format: print Publication details: York : University of York, Centre for Health Economics, York Health Economics ...
Managerial and Decision Economics 28.4-5 (June-August 2007): 267-283. ... Scherer, F.M. "Uncertainty and Choice: The Challenges of Pharmaceutical Efficacy, Safety, and Cost." ...
"Endogenous Productivity of Demand-Induced R&D: Evidence from Pharmaceuticals." RAND Journal of Economics 50, no. 3 (Fall 2019 ... We examine trends in the productivity of the pharmaceutical sector over the past three decades. Motivated by Ricardos insight ...
... draws on this experience to provide world-class research and education in pharmaceutical medicine. ... The UK has a strong tradition of medicines development and the Centre for Pharmaceutical Medicine Research (CPRM) ... A European Centre of Excellence for Pharmaceutical Medicine* • Module accreditation by Faculty of Pharmaceutical Medicine** • ... The Centre for Pharmaceutical Medicine Research (CPRM) draws on this experience to provide world-class research and education ...
South East Asia Pharmaceutical Markets Jamie Davies October 2014 - Download as a PDF or view online for free ... Price controls • Promotion of generic drugs • National drug lists • Reference pricing BMI View: More health economics ... China: Pharmaceutical Market Access by Pacific Bridge Medical. China: Pharmaceutical Market Access. Pacific Bridge Medical•3.8K ... Myanmar Pharmaceutical market an Overview and an Opportunity by Ishan Shukla. Myanmar Pharmaceutical market an Overview and an ...
... draws on this experience to provide world-class research and education in pharmaceutical medicine. ... The UK has a strong tradition of medicines development and the Centre for Pharmaceutical Medicine Research (CPRM) ... A European Centre of Excellence for Pharmaceutical Medicine* • Module accreditation by Faculty of Pharmaceutical Medicine** • ... The Centre for Pharmaceutical Medicine Research (CPRM) draws on this experience to provide world-class research and education ...
... and interviews at three major pharmaceutical companies to examine the effects of liability on product availability, safety, ... Product Liability and the Economics of Pharmaceuticals and Medical Devices. Regular price $55.00. $44.00 Sale ... and interviews at three major pharmaceutical companies to examine the effects of liability on product availability, safety, ...
Danitzas research interests include pharmaceutical economics, Health Technology Assessment (HTA), pricing and reimbursement ... Skip to content London School of Economics and Political Science SearchMenu ... Previous experience includes data analysis and regulatory affairs in the Chilean pharmaceutical market. ... from The Pontifical Catholic University of Chile and an MSc in International Health Policy from the London School of Economics. ...
Pharmaceutical Vaccine Blog/No Category. Posted Dec 16, 2019 by Martin Armstrong. ...
... the Swiss pharmaceutical company, to patent a new version of the leukemia drug Glivec. The latest verdict follows previous ... PETERSON INSTITUTE FOR INTERNATIONAL ECONOMICS. The Peterson Institute for International Economics is an independent nonprofit ... On April 1, the Indian Supreme Court rejected the attempt by Novartis, the Swiss pharmaceutical company, to patent a new ... Our widely recognized specialists on international economics bring their expertise to bear on a vast and diverse range of ...
Pharmaceutical Economics and Policy 552:. This course isnt available for spring 2020. Sorry, there may be a problem with the ... Please browse other Pharmaceutical Economics and Policy courses or contact the department to inquire about this course. ... or Pharmaceutical Economics and Policy 552 may be not be offered every semester.. Note: This course will be offered in Fall ...

No FAQ available that match "economics pharmaceutical"